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1. Ribosome-inactivating proteins (RIPs) have long been used to lesion neurons in 
neuroscience research. However the neuronal toxicity and mechanisms of type I 
RIPs, such as trichosanthin (TCS) and ricin A chain (RTA), are not well understood. 
RTA is the enzymatic chain isolated from ricin. It has a structural similarity with 
TCS. 
2. To study the toxicity and toxic mechanisms of RIPs on neuronal cell types, the eye 
of the rat was used as a model. The toxins were injected at different dosages into 
the vitreous chamber, and the rats were allowed to survive for 1 to 28 days. Only 
one RIP was used on each rat; and only one eye was injected with RIP; the 
contralateral eye was injected with a control solution. To assess the toxic effects, 
data were obtained on retinal thickness, cell counts, histopathological scores, 
immunohistochemical reactivity and fluorescent labeling. 
3. TCS caused distinct changes at a dosage of 0.92 nmol and most of the changes and 
apoptosis peaked at 4 days. -
4. The results showed that TCS was toxic to retinal cells, the effects being most 
pronounced on cells of the outer nuclear layer (ONL), less so on cells of the inner 
nuclear layer (INL), and was not significant on cells of the ganglion cell layer 
(GCL). 
5. The type of cell death induced by TCS was investigated by terminal transferase-
mediated nick-end labeling (TUNEL), immunohistochemistry of cleaved caspase-3 
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and electron microscopy. Apoptosis was found to be the predominant mode of cell 
death, proceeding via the degeneration of mitochondria and activation of caspase-3. 
6. The transport of TCS and its entry into retinal cells were studied by injection of 
conjugated FITC-TCS and observing the retinal sections under the confocal 
microscope. The fluorescent signals first scattered all over the retina, stopping 
abruptly and forming a white bright line at the outer limiting membrane (OLM). 
Subsequently the signals crossed the OLM and entered the pigment epithelial cells. 
Since OLM is formed by Miiller cells, it was suggested that TCS was able to enter 
the Miiller and pigment cells. TCS is a non-glycosylated RIP but it may bind to 
lipoprotein receptor-related protein (LRP) and chemokine receptor (CXCR4) on 
Miiller cell surface and be endocytosed. Intoxication of Miiller cells deprived ONL 
cells of glial support, causing their death by apoptosis. 
7. This hypothesis was supported by observations on glial activities. Glial reactions 
were studied by immunohistochemistry of glutamine synthetase (GS) and glial 
fibrillary acidic protein (GFAP), and labeling with FITC-Griffonia simplicifolia BS-
I isolectin B4 (GS-I-B4). These methods normally demonstrate Miiller cells, 
astrocytes, and microglia respectively. TCS-treated retinas showed a decrease in GS, 
an increase in GFAP, and little change in GS-I-B4. 
8. RTA mainly resulted in a dose-dependent, acute retinal inflammation and necrosis. 
- Some apoptotic cells were present as revealed by TUNEL and cleaved caspase-3 
immunhistochemistry. RTA is a glycosylated RIP possessing a mannose sugar. It 
may be hypothesized that RTA entered and damaged vascular endothelial cells via 
the mannose receptors in the cell membrane, causing leakage of blood vessels and 
hence inflammation and necrosis. The glial reactions after RTA treatment differed 
from those after TCS treatment: GFAP expression and GS-I-B4 signals were much 
stronger than those in TCS experiment. This suggests that RTA produced a stronger 
toxic effect on the rat retina than TCS. 
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9. Ricinus communis agglutinin (RCA) is a type II RIP since it has both a RIP A chain 
and a cell-binding (lectin) B chain. It is included in the study for comparison. RCA 
caused very similar toxic effects on retinas as RTA. The results suggested that target 
cells possessing a certain kind of receptors are similarly intoxicated by RIPs with or 
without the B chain, as long as the A chain has a ligand domain for those receptors. 
The toxicity of RCA to retina might also be brought about by its effect on blood 
vessels. 
10. The results show that small differences between TCS and RTA molecules results in 
different mechanisms of toxicity. The difference between RTA and RCA toxicities 
showed that the B chain is not an obligatory requirement for RIP toxicity. The 
difference between RTA and TCS toxicities showed that even a sugar-receptor 
binding is not necessary. The toxicity of different RIPs depends on the properties of 
the cell membrane of the target cells. 
11. Some previously unreported observations were made: (i) We used Royal College of 
Surgeons rats for the control experiments. The results showed that activation of 
caspase-3 was involved in the apoptosis of the photoreceptors of these rats. The 
results may help to understand this inherited abnormality of the RCS rats, (ii) FTTC 
was found to selectively label nuclei of INL; as such, it may be a useful tracer. 
— • 
12. The RTA-treated eyes may be used as a model for research on acute retinal 
inflammation/necrosis, and the TCS-treated eyes as a model for research on retinitis 
pigmentosa. TCS, causing rapid deletion of cells in ONL and INL without 
significant inflammatory signs, might be a candidate for the chemotherapy of 
retinoblastoma, a malignancy mainly derived from the ONL and INL. 
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CHAPTER 1. INTRODUCTION 
1.1 Overview 
This project studied the effect of trichosanthin (TCS) and ricin A chain (RTA) on retinal 
neurons, which are located in the ganglion cell layer (GCL), inner nuclear layer (INL) 
and outer nuclear layer (ONL) of the retina. TCS and RTA were administered by 
injection into the vitreous chamber, from which they would diffuse into the retina. This 
project was a combination of quantitative and qualitative studies. 
TCS and RTA belong to a class of proteins known as ribosome-inactivating proteins 
(RIPs), which can be divided into two types, type I and type II. Both TCS and RTA 
belong to type I. We compared the effects of TCS and RTA; in addition their effects 
were compared with those of ricinus communis agglutinin (RCA), a type II RIP. There 
have been no reported studies on the effects of RIPs on the retina, let alone on the 
mechanism of toxicity on the retinal neurons. The mechanisms of their entry into the 
retinal neurons and their toxicity were also investigated. 
1.2 Ribosome-inactivating proteins (RIPs) 
RIPs are a family of toxic proteins that cause cell death by inactivating ribosomal RNA 
(rRNA), thereby inhibiting the protein synthesis of the cell (Wiley 1994; Peumans et al 
2001). Many plants contain RIPs. Some bacteria and fungi produce proteins that can 
also inhibit ribosome activities. 
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1.2.1 Classification 
RIPs were first classified into two major types, type I and type II，by Stirpe & Barbieri 
(1986). This classification has been widely accepted and is commonly used (Lord et al 
1994; Wiley 1994; Sandvig & van Deurs 1999，2000). 
Type I RIPs consist of only a single rRNA-cleaving domain. Most of them are 
constructed of a single intact polypeptide of molecular weight around 30 kD. Besides the 
above typical type I RIPs, there are also a few RIPs that are composed of two rRNA-
cleaving polypeptides held together by noncovalent interactions. These proteins have 
been called two-chain type I RIPs (Peumans et al 2001). To avoid confusions, in this 
thesis, the term type I RIP only refers to the typical type I RIPs. 
Type II RIPs comprise one or more rRNA cleaving, amino-terminal domains, which are 
commonly called A chain; they resemble type I RIPs. They are each linked to a 
structurally unrelated carboxyl-terminal domain called B chain by a disulfide bond (Lord 
et al 1994; Sandvig & van Deurs 1999，2000; Peumans et al 2001). Both A_and B chains 
are synthesized on a single precursor that is post-translationally processed by the 
excision of a linker sequence between the two chains (Peumans et al 2001). 
Besides the typical type II RIPs, a 60 kD RIP (JIP60) has been isolated from barley. 
This RIP is composed of an amino-terminal domain similar to type I RIPs and a 
carboxyl-terminal domain with unknown function (Reinbothe et al 1994). JIP60 has 
- 2 -
been named a type III RIP. The experiments and discussions of this thesis concern only 
types I and II RIPs. 
1.2.2 Structure 
Many type I and II RIPs have been sequenced and/or cloned for their primary structures. 
On comparing the amino acid sequences of RIPs, striking similarities between type I 
RIPs and the A chains of type II RIPs, as well as those among the B chains of different 
type 11 RIPs, have been shown. Close examination shows that the sequence matching 
between type I RIPs and the A chains of type II RIPs is much higher than that among the 
B chains of type II RIPs (Peumans et al 2001). 
The three-dimensional crystallographic structures of some type I and II RIPs have been 
well studied. In general, the tertiary structures of different RIPs are well preserved, as 
illustrated by the fact that the a-carbon traces of most RIPs are almost superimposable. 
Nevertheless, some major differences exist especially in the B chains and surface loop 
structures (Peumans et al 2001). 
It has been suggested that the diverse primary and three-dimensional structures of 
variable RIPs account for differences in their toxicity, and in the underlying mechanisms 
of their enzymatic activities and substrate selectivity. 
1.2.3 Enzymatic activities 
It has been widely accepted that all RIPs are enzymes and have numerous enzymatic 
activities, which include classical and novel enzymatic activities. 
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Classical enzymatic activities - RIP functions 
All RIPs can enzymatically damage ribosomes, but they have diverse mechanisms of 
attacking rRNA (Brigotti et al 1989; Fong et al 1991). Plant RIPs, such as ricin and 
modeccin, as well as bacterial RIPs, such as Shiga toxin from Shigella dysenteriae and 
Shiga-like toxin I from Escherichia coli, act as a N-glycosidase (Wellner et al 1994)， 
which cleaves a single N-glycosidic bond between adenine and ribose at a specific 
nucleotide A-4323 near the 3’ terminus of the 28S rRNA of the mammalian 60S 
ribosomal subunit (Endo et al 1987; Perentesis et al 1992; Gluck et al 1994). Fungal 
RIPs, such as alpha-sarcin from Aspergiluus giganteus, act as a specific endonuclease 
(Perentesis et al 1992), which cleaves a single phosphodiester bond between G-4325 and 
A-4326 of the same rRNA of the 60S ribosomal subunit, just one nucleotide away from 
the site of action of plant and bacterial RIPs (Brigotti et al 1989). This region of RNA is 
essential to elongation factor-dependent ribosomal functions and is located within the 
- ribosomal binding domain of elongation factors (Funitani et al 1992; Perentesis et al 
1992). ‘ 
Novel enzymatic activities - DNase functions 
Numerous efforts have been made to investigate the novel DNase activity that RIPs 
possess. Some of the RIPs that possess N-glycosidase activity, including the plant RIPs 
TCS (Li et al 1991), ricin and luffin, as well as the fungal RIP alpha-sarcin (Ling et al 
1994)，have been reported to express the enzymatic activity to cleave supercoiled 
double-stranded DNA. In general, it was suggested that the DNase activities of RIPs 
only occur at high concentrations. Some researchers also suggested that the DNase 
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activity was due to contamination of nucleases and could be removed by purification of 
RIPs (Day et al 1998). The mechanisms remain unclear and the controversy attracts 
research on DNase activity of RIPs. 
1.3 Type II RIPs 
As glycoproteins, with mannose being the most abundant sugar, type II RIPs have a 
neutral or slightly acidic PI. Their A chain has a molecular weight of about 30 kD and 
produces the toxic effect of ribosome inactivation. Their slightly larger B chain binds to 
sugars with a D-galactose configuration, and therefore can bind to galactose receptors on 
almost all eukaryotic cell surfaces. The association of the B chain with the A chain 
greatly increases the toxicity of type II RIP molecules, since the B chain facilitates entry 
of the molecules into cells (Stirpe & Barbieri 1986). Ricin, abrin, modeccin, and 
volkensin are common examples of type II RIPs. 
1.3.1 Ricin 
Ricin, the most classical and best studied of type II RIPs, has been discovered for more 
than one century since Stillmark extracted the toxic principle from the seeds of Ricinus 
communis, commonly known as castor beans (Stillmark 1888). It was well known in the 
Second World War for its extreme toxicity. Ricin was once considered a potential 
candidate in biochemical warfare research. 
There is some confusion in the nomenclature of ricin, as ricin occurs in several 
molecular forms (isoforms), which have different combinations of ricin A and B chains. 
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The name 'ricin' can be used with a broad meaning to include all these forms. Here, 
'ricin' or 'ricin toxin' is understood to refer to a dimer with a molecular weight of about 
60 kDa, consisting of one A chain and one B chain connected by a disulphide bond 
(Sandvig & van Deurs 1996, 1999; Olsnes et al 1999). 
The amino acid sequence and the three-dimensional, globular structure of ricin had been 
found (Montfort et al 1987). Both A and B chains are glycosylated, containing mannose 
and glucosamine (Olsnes et al 1975; Thorpe 1985); otherwise there is hardly homology 
between them (Villafranca & Robertus 1981). Approximately 50% of the A chain of 
ricin consists of a-helices and B-sheets, in which three individual domains are 
distinguished. A cleft at the interface of the three domains forms the active site for rRNA 
N-glycosidase activity for ribosome inactivation (Endo & Tsumgi 1987; Endo et al 1987; 
Montfort et al 1987). Its sugar-binding B-chain is a bilobal structure consisting of two 
homologous domains, each of which contains one galactose binding site lying in a ‘ 
pocket formed in part by a kink in the polypeptide chain by the tripeptide Asp-Val-Arg. 
1.3.2 Ricinus communis agglutinin (RCA) 
Ricinus communis agglutinin (RCA) is closely related to the above toxin ricin and is 
often grouped under 'ricin', which however has a broader meaning as explained above. 
RCA is a tetramer, composed of two ricin-like dimers. It therefore has two A chains and 
two B chains and has a molecular weight of about 120 kD. 
Being type II RIPs, both ricin and RCA possess RIP and cell-binding properties. The 
latter property causes blood cells to agglutinate. However, their potencies differ. Ricin is 
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1000-2000 times more toxic to mice, and 20 times more toxic to culture cells, than RCA, 
and hence is commonly known as a toxin. On the other hand, RCA has a much stronger 
agglutinating activity on erythrocytes than ricin, and therefore is generally known as an 
agglutinin (Saltvedt 1976; Bhattacharyya & Brewer 1988). Because of its weaker 
toxicity, RCA is used for comparing the toxic effect of different RIPs. 
1.3.3 Intracellular mechanism 
Since RIPs attack targets inside the cell, namely ribosomes, it is important to investigate 
their intracellular mechanisms. After binding to cell surface receptors with their B chain, 
the molecules of type II RIPs are endocytosed and transported to different intracellular 
destinations; finally they cross the membrane in which they are contained, to enter the 
cytosol and damage ribosomes (Sandvig & van Deurs 2000). As the most classical 
example of type II RIPs, ricin is the best studied RIP, and the following account on 
intracellular mechanisms of type II RIP therefore derived mainly from studies on ricin. 
In normal cells, proteins of the cytoplasmic matrix and the nucleus, and some of the 
mitochondrial proteins, are synthesized by free ribosomes; secretory, lysomal and 
integral membrane proteins are synthesized by ribosomes bound to rough endoplasmic 
reticulum (rER). The latter proteins are then transferred into the lumen of the 
endoplasmic reticulum. The ER lumen is the major environment where the synthesized 
proteins become folded and assume their biologically active conformations and, in the 
case of certain proteins, assembled into multimeric complexes (Helenius et al 1992). 
There also, proteins are modified as secretory or lysomal proteins, and are delivered to 
the Golgi apparatuses. For the latter transport, they are packaged into ER-to-Golgi 
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transport vesicles (Rothman 1994). Only those having been folded and assembled 
correctly are able to leave the ER, whilst the proteins failing to do so are exported from 
the ER and disposed of by proteolytic degradation in the cytosol (Brodsky & McCracken 
1997; Lord et al 2000). 
The pathway of the toxic proteins (type II RIPs) entering and attacking cells is just 
reversed as follows. 
Endocvtosis 
The terminal galactose of ricin B chain binds to both glycolipids and glycoproteins, 
which are distributed over nekly the whole cell surface. Then the whole molecule of 
ricin toxin (consisting of A and B chains) is internalized by clathrin-dependent and 
clathrin-independent endocytosis (Sandvig & van Deurs 2000). The structural difference 
among the binding B chains of type II RIPs determines their binding to different sugar-
containing receptors on the cell surface, and therefore type II RIPs show some selective 
cellular toxicity (Barbieri et al 1993). For example, ricin induces 50% cell death at the 
concentration of Ing/ml, while elderberry type II RIP has no effect at even Img/ml 
(Battelli et a 1997). 
Transport to the Golgi apparatus 
After endocytosized following its B chain binding to the cell membranes, ricin 
molecules in endosomes are transported either back to plasma membrane or to the Golgi 
apparatus (Gonatas et al 1980; Sandvig & van Deurs 1996). Both pathways are under 





Simons 1997; Llorente et al 1998). A relatively small fraction of endocytosed ricin 
molecules is transported to the Golgi apparatus, but this is enough to cause the extreme 
toxicity of ricin (van Deurs et al 1988; Sandvig and van Deurs 1996). 
Retrograde transport to the endoplasmic reticulum (ER) 
Retrograde intracellular transport is the reverse of the secretory pathway, which 
proceeds from the ER to the cell surface. Retrograde axonal transport refers to the 
transport from the axon towards the cell body, and belongs to another subject of study. 
Ricin and some other type II RIPs, such as Shiga toxin and cholera toxin, can be 
retrogradely transported from the Golgi apparatus to the ER (Sandvig et al 1992; Majoul 
et al 1996; Rapak et al 1997). The disulfide bond between the A and B chains is believed 
to be cleaved in the ER. It has been reported that the interaction between the A chain and 
an ER retrieval sequence promotes the retrograde transport of the toxin to the ER, and 
hence significantly increases the cytotoxicity of the toxin (Wales et al 1993). The 
cytotoxicity of the A chain can be inhibited by treating cells with brefeldin A, which 
prevents the assembly of coat proteins on budding vesicles of the Golgi apparatus, and 
by overexpressing mutant GTPases, which inhibit retrograde transport of toxins from the 
Golgi to ER (Simpson et al 1996). Nevertheless, the detailed mechanism of the 
retrograde transport is still not clearly understood. 
Translocation to the cytosol 
It has been suggested that the B chain remains in the ER after its disulfide bond with the 
A chain is cleaved there. Since the destructive enzymatic part of the toxin is the A chain, 
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this moiety has to be translocated to the cytosol to reach ribosomes (Sandvig and van 
Deurs 2000). 
However the B chain of some type II RIPs, such as Shiga B chain, is also reported to 
induce DNA cleavage and apoptosis by activating the caspase cascade. This would 
suggest that the B chain may also be translocated to cytosol and produce such an effect 
(Nakagawa et al 1999). 
In activation of ribosomes 
In the cytosol, the A chain of type II RIPs, such as ricin A chain, has an N-glycosidase 
activity which cleaves specifically the N-glycosidic bond of A4324 of 28S rRNA of the 
60S ribosomal subunit (Endo & Tsurugi 1987; Endo et al 1987). This inhibits the GTP-
dependent binding of elongation factor 2 (EF2) (Brigotti et al 1989). The result is the 
inactivation of ribosome, cessation of protein synthesis and eventually death of the cell. 
1.3.4 Application of RIPs in neuroscience research: suicide axonal transport 
Functional neuroanatomy and neuroscience researches have long relied on toxins to 
produce neuronal lesions for mapping neuronal projections and locating their cell bodies 
(Muramoto et al 1984; Wiley 1992; Wiley & Lappi 1994). The method made use of the 
retrograde axonal transport of toxins, or the so-called suicide transport. RIPs, usually 
type II ones, have been widely used because of their high inhibitory activity on protein 
synthesis, which has been ascribed to the cell-binding capability of the B chain. 
Suicide axonal transport 
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Suicide axonal transport means that toxins are taken up and retrogradely transported 
along the axon to the cell body, where processes leading to cell death occur (Harper et al 
1980; Wiley et al 1982). The toxin is usually injected intraneurally or at the axon 
terminals. At the injection site, the toxin is taken up by receptor-mediated endocytosis 
(van Deurs et al 1985). Initial studies on suicide transport developed from the use of 
lectins as neuroanatomical tracers. Lectins are glycoproteins or proteins that are able to 
bind specifically to various sugar moieties. Some RIPs are lectins. Lectins, including 
wheat germ agglutinin (WGA), ricin, phytohemagglutinin (PHA), and concanavalin A 
(Con A)，were injected into the anterior eye chamber of rats. Following the injection 
they were found to be retrogradely transported along adrenergic nerve fibres to the 
superior cervical ganglion (Stoeckel et al 1977; Dumas et al 1979). Some lectins -are 
toxic, and many of the toxic lectins are RIPs. Toxic lectin RIPs include abrin, modeccin, 
ricin and volkensin. Ricin is the most commonly used lectin RIP to produce neuronal 
lesions in neuroanatomical studies. 
Ribosome inactivation readily kills the cell (Olsnes & Pihl 1982); only one free 
molecule of type II RIPs, such as ricin, in cytoplasm is enough to kill the cell (Eiklid et 
al 1980). The result of administrating these type II RIPs to the nervous system is a 
necrotic damage at the injection site, and destruction of neurons that project into the 
- injection site (Wiley et al 1982; Wiley & Stirpe 1987). 
Apart from neuroscience research, suicide transport has the potential use as a tool for 
precision chemical surgery. Specifically, it may be used to delete hyperactive neurons to 
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alleviate chronic muscle contracture, or to delete sensory neurons to alleviate chronic 
pain (Yamamoto et al 1983，1984，1985). 
1.4 Type I RIPs 
Type I RIPs have molecular weights ranging from 26 to 32.5 kD. They have only an 
enzymatic polypeptide chain that possesses N-glycosidase activity, but no cell-binding B 
chain. Type I RIPs resemble the A chains of type II RIPs and are therefore toxic when 
taken up by cells. 
In China, a type I RIP, trichosanthin (TCS) has been used as a traditional Chinese 
medicine for centuries (Anonymous 1976). In western countries, a plant protein, 
Phytolacca Americana antiviral protein (PAP), has long been known to inhibit the 
transmission of tobacco mosaic virus in plants (Duggar & Armstrong 1925). But only 
.until recent decades were their enzymatic activities recognized as type I RIPs (Dallal & 
Irvin 1978^ Shaw et al 1994). Agrostin, gelonin, luffm and saporin are examples of type “ 
I RIPs as well (Sitrpe & Barbieri 1986). 
Without the help of a binding B chain, type I RIPs express variable toxicity. For instance, 
barley RIP (type I RIP) is nontoxic to intact cells (Ovadia et al 1988; Wiley & Lappi 
1994), while another type I RIP, trichosanthin shows selective toxicity to different cell 
types (Wang 1990). 
1.4.1 Trichosanthin (TCS) 
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Trichosanthin is the typical example of type I RIPs. Trichosanthin or Tian Hua Fen in 
Chinese is commonly used in traditional Chinese medicine as an abortifacient drug for 
early and mid-gestation. It is obtained from the root tuber of Trichosanthes Kirilowii 
Maxim of the Cucurbitaceae family. Its purified effective principle is a basic protein 
named a-trichosanthin (TCS), which differs from p-trichosanthin, as the latter comes 
from T. cucumeroides. In this thesis, a-trichosanthin is simply referred to as 
trichosanthin or TCS. Although TCS has been used for abortion for hundreds of years in 
China, the scientific research on it started around 1966 and many of early studies were 
not published (Wang 1990). The first publication on TCS appeared in 1976 (Anonymous 
1976). Since then, more and more biochemical and pharmacological studies have been 
carried out by researchers in China, Hong Kong and western countries (Chang et al 1985; 
Wang 1990). 
TCS was found to be a type I RIP when it was added to cultured tumor cells and caused 
- a reduction in the uptake of radioactive precursors for protein synthesis (Tsao et al 1990). 
This suggested that TCS killed cells by RIP activity. TCS is a single polypeptide chain 
with a molecular mass of 25-26 kDa. It possesses amino acid sequence homologous to 
the A chains of many type II RIPs, such as ricin A chain (Kubota et al 1987; Maraganore 
et al 1987; Collins et al 1990). It inhibits protein synthesis through cleavage of the N-C 
glycosidic bond of adenine 4324，the 4324'^ base of 28S rRNA. This action renders the 
ribosome unable to bind elongation factor 2 and therefore terminates translation (May et 
al 1989; Collins et al 1990; Ko et al 1992; Zhang & Liu 1992; Wong et al 1994; Au et al 
2000; Xia & Sui 2000). 
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TCS owns a wide spectrum of biological and pharmacological activities. It produces 
adverse effects on reproduction in the mouse by causing follicular atresia and 
degeneration of ovulated oocytes (Ng et al 1991). In fertilized animals, TCS results in 
necrosis of syncytiotrophoblasts of placental villi, and consequently the embryo fails to 
develop (Anonymous 1976; Liu et al 1985; Tarn et al 1985; Wang 1985). This action has 
been related to its uptake by placental trophoblast cells (Anonymous 1976; Wang 1990). 
TCS also possesses immunomodulatory (immunosuppressive), anti-tumor, anti-viral, 
and anti-human immunodeficiency virus (HIV) activities (Leung et al 1986; Collins et al 
1990; Shaw et al 1994; Takemoto 1998; Vlietinck et al 1998; Zhao et al 1999; Au et al 
2000). The fact that TCS is used to treat choriocarcinoma is consistent with its abortive 
activity, since this tumor also originates from fetal trophoblast cells (Maraganore et al 
1987). Its anti-HIV activity is because of its inhibition of the replication of HIV and its 
cytotoxicity to HIV-infected macrophages and lymphocytes (Byers et al 1994; Zheng et 
al 1995). 
/n vitro and in vivo studies showed that the toxicity of TCS differs in different cell types. 
TCS is toxic to trophoblastic cells, choriocarcinoma cells, melanoma cells, liver cells 
and proximal tubule epithelial cells (Tsao et al 1986，1990; Collins et al 1990; Ko & 
Tarn 1994; Tang et a 1997). However, TCS produced no morphological signs of toxicity 
in brain cell culture (Pulliam et al 1991). Intramuscular injection of TCS did not alter the 
concentration of beta-endorphin in the mouse brain (Ng et al 1993), and intravenous 
injection of TCS did not affect the b-endorphin levels in the brain and pituitary (Ng et al 
1996). Neither has TCS any effect on hepatoma cells (Tsao et al 1990). 
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The insertion of TCS into cell membrane depends the pH at the membrane surface (Xia 
& Sui 2000) and the pathways of its insertion show variable patterns. TCS enters 
trophoblasts by binding to lipoprotein receptor-related protein (LRP). It enters proximal 
tubule epithelial cells by binding to megalin. It inserts into HIV via chemokine receptors 
(Zhao et al 1999; Chan et al 2000b). 
Furthermore, TCS has been reported to cleave the circular or supercoiled form of DNA 
(Li et al 1991). Some studies have also reported that it induced apoptotic cell death (Kerr 
et al 1994; Ru et al 2000; Zhang et al 2001). This is generally not expected of RIPs 
since apoptosis involves the synthesis of new proteins. This opens the question what -
leads to cell death when ribosomes are inactivated? 
1.4.2 Ricin A chain (RTA) 
Ricin A chain (RTA) is isolated from the type II RIP ricin, and is the moiety that 
possesses the toxic activity to specifically depurinate the 28s ribosomal RNA (Wales et 
al 1993). Without the association with a B chain, the free enzymatic chain RTA belongs 
to type I RIPs, though it does not exist naturally by itself. The purified RTA is a protein 
with a molecular weight of 30 kDa and contains mannose residues (Zenilman et al 1988). 
Generally, RTA alone is considered to be non-toxic or has a low toxicity to whole cells 
(Sandvig & van Deurs 1996). Conjugation of RTA with a cell-binding target specific 
moiety such as a hormone or a monoclonal antibody, increases the toxicity and target-
specific of RTA (Simmons et al 1986; Wiley 1994). Therefore, studies are mostly 
focused on synthesized hybrids of the toxin. 
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However, some studies have reported the selective cytotoxicity of free RTA. It has been 
demonstrated that RTA is specifically taken up by rat bone marrow macrophages 
through mannose receptor-mediated endocytosis (Simmons et al 1986). It has also been 
revealed that RTA is taken up by rat hepatic nonparenchymal cells, while liver 
parenchymal cells only display minimal nonspecific uptake of RTA (Skilleter & Foxwell 
1986). The uptake is inhibited by D-mannose, suggesting the binding of RTA to 
mannose receptors on the cell surface. The uptake of RTA into Kupffer cells is also by 
mannose receptor-mediated endocytosis (Zenilman et al 1988). 
The mechanisms of RTA entry into cells and their intracellular pathways may diverse. 
RTA, like the A chain cleaved intracellular from whole ricin molecules, has to be 
translocated into cytosol before they can act on rRNA (Simpson et al 1996). Studies on 
the intracellular pathways of type I RIPs are rare. 
Although ricin and TCS are obtained from unrelated families of plants, there is a high 
degree of homology in the amino acid sequence between TCS and RTA (Kubota et al 
1987; Maraganore et al 1987; Zhou et al 1994). The mild difference between TCS and 
RTA may decide their uptake by different cell types and different toxicity. Few studies 
have been reported on the effects of type I RIPs on neurons. 
1.4.3 Medical applications: immunolesioning and immunotherapy 
The old idea that toxins might be targeted against specific cell types, such as cancer cells, 
was originally proposed by Paul Ehrlich (Ehrlich 1957). Now, many toxin conjugates, 
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such as immunotoxins, have been tested clinically with promising effects on both solid 
tumours and haematological malignancies (Frankel et al 1996, 2000a; Laske et al 1997; 
Kreitman 1999;). The toxins in these studies are usually type I RIPs or the A chains of 
type II RIPs, since they can induce ribsome inactivation and cause cell death when taken 
up by cells, and the conjugated monoclonal antibodies can select the target cell type and 
bring the toxin into the cell. 
On the other hand, it has recently been suggested that the B chains of type II RIPs, for 
instance, Shiga toxin B-fragment, could act as a vehicle to carry proteins into cells to 
induce antiviral immunity; that is, they are used cis non-living and non-toxic vaccine 
vector. (Lee et al 1998). Similarly, immunotherapy against cancer cells may be 
developed using the B chain. 
Further studies on the uptake and transport mechanism of RIPs, and the biochemical 
properties of the cancer cells, may help to produce a class of highly specific and 
effective cancer-treating toxins. ‘ 
1.5 The types of cell death 
Generally, cell death has been classified into two major types: necrosis and apoptosis. 
The latter type is also referred to as programmed cell death (PCD) (Champagne et al 
1999). These two kinds of cell death possess distinct differences in their morphological 
and biochemical features (Wyllie et al 1980), and may occur as a continuum of each 
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other or simultaneously (Leist et al 1997). The intensity of insult has been reported to 
decide the prevalence of the type of cell death (Dypbukt et al 1994; Bonfoco et al 1995). 
1.5.1 Necrosis 
Necrosis is passive cell death usually resulting from injury or excess calcium influx 
during excitotoxicity. It occurs in pathological situations such as ischemia, seizure and 
trauma. (Wolozin & Behl 2000). The cells undergoing necrosis are morphologically 
characterized by initial cellular and organelle swelling, and subsequent disruption of 
nuclear, organelles, and plasma membranes. Later, nuclear structures and cytoplasmic 
organelles disintegrate, and in the final stage the cell contents are extruded into the 
extracellular space (Majno & Joris 1995). Necrosis is considered as an unregulated form 
of cell death, since it may result in successive damage to surrounding cells through 
release of cellular contents (lysosomal proteases and neurotransmitters) and by 
triggering inflammation (Neumar 2000). 
1.5.2 Apoptosis 
Programmed cell death (PCD) is a regulated physiological suicide program that allows 
controlled elimination of unwanted cells with minimal effect on surrounding tissue. PCD 
is crucial for the growth and maintenance of healthy tissues. Apoptosis includes PCD 
and refers to the process of cell suicide under any condition when carried out actively by 
a cascade of executioner proteases (Wolozin & Behl 2000). This kind of cell death is 
morphologically characterized by membrane blebbing, DNA fragmentation and 
margination, cytoplasmic shrinkage and condensation with preservation of organelles; in 
the final stage there is cytoplasmic budding to form membrane-bound fragments called 
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apoptotic bodies (Kerr et al 1972). Since apoptotic bodies are phagocytized by 
macrophages, the contents of dead cells never enter the extracellular space (Savill et al 
1993). 
The mechanism of apoptosis was first studied in the immune system. In general, 
apoptosis is induced by stimuli that trigger one of the two known cell death signaling 
pathways: the intrinsic and extrinsic pathways (Roy & Nicholson 2000; Wolozin & Behl 
2000). 
The intrinsic pathway depends on the balance of antiapoptotic and proapoptotic Bcl-2 
family members. The resulting death signals lead to some changes in the mitochondria 
-including release of polypeptide agents, such as cytochrome c and second 
mitochondria-derived activator of caspases (SMAC) or direct lAP-binding protein with 
low pi (Diablo). The former binds to oligomerization mediator Apaf-1, which then 
associates with procaspase-9, and thereby triggering caspase-9 activation; the latter 
interacts with the BIR (baculoviral lAP repeat) domains of inhibitors of apoptosis 
protein (lAPs) that would otherwise block the actions of caspases (caspase-3, 7 and 9). 
The extrinsic pathway is modulated by the availability of the molecular components 
(ligands) and dominant-negative regulators such as death receptors (e.g. Fas) and 
cFLIP/usurpin. Variable death ligand-receptor complexes lead to the enrollment and 
activation of procaspase-8 via the adapter molecule FADD/Mortl. 
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The subsequent activations in both pathways are alike. The majority of proteolytic 
cleavage events are mediated by caspase-3 and caspase-7, which both become fully 
activated when cleaved by the upstream caspases, such as caspase-8 from the extrinsic 
pathway and caspase-9 from the intrinsic pathway. The proteolytic cascade cumulates in 
apoptosis. 
There is interaction between the two apoptotic pathways, which occurs via the 
proteolysis of BID (a member of Bcl-2 family) that normally serves an antiapoptotic role 
within the intrinsic pathway until it is truncated by caspase-8 (derived from the extrinsic 
pathway). The truncated BID (tBID) then induces cytochrome c release and hence the 
intrinsic pathway. In theory, extrinsic signals may involve the intrinsic pathway to 
induce apoptosis, such as when the signal is weak or when the lAP barrier is high. 
The apoptotic pathways in neurons are somewhat different (Wolozin & Behl 2000). In 
the extrinsic pathway, neuronal apoptosis occurs most commonly through a loss of 
trophic signaling, such as growth factors. This differs from the signal gain described ‘ 
above for systems such as the immune cells. Loss of growth factor stimulation boosts the 
amount of dephosphorylated-BAD (a member of Bcl-2 family), which inactivates Bcl-2, 
resulting in activation of caspase-3 and finally apoptosis. In neuronal apoptosis, the 
cleavage is deficient in the activation of caspase-7, which is another divergence. 
In the apoptosis of retinal ganglion cells, the activation of the tumor-suppressor protein, 
p53 by either loss of neurotrophic support or overexposure to excitatory amino acids, 
has been reported to be one of the primary regulatory steps (Oppenheim 1991; Levine 
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1997; Nickells 1999). Subsequently, the expression of proapoptotic gene bax is up-
regulated, and the antiapoptotic gene Bcl-2 down-regulated. The mitochondria become 
swollen; the outer mitochondrial membrane ruptures and allows the escape of 
cytochrome c to the cytosol. Afterwards, the cleaved caspase-9 activates caspase-3 and 
triggers the apoptotic process of the ganglion cells (Kermer et al 1999; Nickells 1999; 
Barber et al 2001; Meyer et al 2001). The cells in the inner nuclear layer and outer 
nuclear layer have also been reported to have a caspase-3-like activity during apoptosis, 
in which mitochondrial swelling and cytochrome c release are also involved (Liu et al 
1999; He et al 2000; Chen et al 2001，Singh et al 2001). Taken together, caspase-3 
seems the most common apoptotic executor in most of the tissues including the retina. 
1.6 Inflammations 
- Inflammation is a reaction of the microcirculation that is characterized by movement of 
fluid and leukocytes from the blood into the extravascular tissues, and the production of 
inflammatory mediators (Rubin 2001). Depending on the persistence of the injury, 
clinical symptomatology, and nature of the inflammatory response, inflammation has 
historically been classified as either acute or chronic inflammation. 
1.6.1 Acute inflammation 
There are three hallmarks of acute inflammation: (i) accumulation of fluid and plasma 
components in the affected tissue, which causes edema of the tissue; (ii) intravascular 
stimulation of platelets; and (iii) presence of polymorphonuclear leukocytes. 
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Alterations of the micro vasculature regulated by vasoactive mediators are among the 
earliest responses to tissue injury and promote fluid accumulation in tissues. The wall of 
venules is normally sealed by tight junctions between adjacent endothelial cells. During 
mild inflammation, the endothelial cells separate and permit passage of the fluid 
constituents of the blood. With severe reaction, the endothelial cells form blebs and 
separate from the underlying basement membrane. Areas of denuded basement 
membrane allow prolonged escape of fluid elements from the micro vasculature. The 
vascular permeability is up-regulated by vasoactive mediators, which are primarily 
released from circulating platelets, tissue mast cells, basophiles, polymorphonuclear 
leukocytes, endothelia cells, monocytes including macrophages, and the injured tissue 
itself. 
1.6.2 Chronic inflammation 
Chronic inflammation is usually observed as the primary response to viral infections, 
certain autoimmune, diseases, parasitic infestations, and malignant tumors. In contrast to 
acute infiltrate, the characteristic cell components of chronic inflammation are 
lymphocytes, plasma cells, and macrophages. 
1.6.3 Retinitis 
Ritinitis is the inflammation of the retina. In most cases retinitis is secondary to 
inflammation of the choroid, and inflammation of the retina as the primary cause is rare 
(Duke-Elder 1964). Acute retinal inflammation is a rare case, but when it occurs it 
causes rapid necrotic damage. On the other hand, retinitis pigmentosa (RP) is one of the 
most common inherited eye disorders. It is a slow, bilateral degenerative disease of the 
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retina, and has its onset in childhood (usually 6 to 12 years of age). The degeneration is 
accompanied by inflammatory changes. RP often results in blindness because of loss of 
rods and cones photoreceptor cells (Vaughan et al 1962; Landers et al 1977). The loss 
was reported to involve apoptosis (Yoshimura 2001). Without an effective treatment, RP 
is a factor of blindness among the young population. 
1.7 Eye model for neurotoxicity studies in CNS 
Previous in vivo studies reported that the type I RIP TCS, did not show much toxicity to 
the central nerve system (CNS) (Ng et al 1996)，perhaps because of its dilution by 
intravenous injection and rapid diffusion from the organ observed, or because of its 
specificity to certain neuronal cell types. In this regard, the eye model provides a number 
of advantages. The retina is a CNS structure. It has a well-developed multilayer 
structure that facilitates easy recognition of different neuronal types. It is a closed 
system where the injected materials remain in the vitreous body for a long time (Jen et al 
1998). -
The retinal architecture is well structured and composed of ten layers, four of which are 
retinal cellular layers (Fox 1993; Saude 1993). Counting from the choroid, the layers 
are: 1. pigment epithelium; 2. photoreceptor layer consisting of outer and inner segments 
both containing rod and cone receptors; 3. outer limiting membrane formed by the 
processes of Miiller cells; 4. outer nuclear layer composing of cell bodies of rods and 
cones; 5. outer plexiform (synapse) layer; 6. inner nuclear layer including cell bodies of 
bipolar, horizontal, amacrine, interplexiform and Miiller cells; 7. inner plexiform 
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(synapse) layer; 8. ganglion cell layer; 9. nerve fibre layer made up of axons of ganglion 
cells; and 10. inner limiting membrane also formed by processes of Miiller cells. Layer 
10 is the nearest to the vitreous chamber, where the toxins were administrated. With this 
clear distinction into layers of different neuronal types, the retina provides an ideal site 
to observe the selectivity of drug actions on neurons having different morphological or 
physiological properties. 
1.8 Objective of present study 
Studies of the effects of type I RIPs on the nervous systems are scarce. The aim of this 
project was to study the neuronal toxicity of type I RIPs to different types of neurons in 
the central nervous system using the retina as the experimental model. The mechanisms 
of the type I RIP toxicity were investigated. The reaction of glial cells was examined. 
Type II RIP was included in this study for comparison. The loss of retinal cells caused 
by RIPs may create an animal model for partial denervation of the retina. The selective 
toxicity of type I RIPs to retinal cells may be of potential value -to the treatment of eye 
diseases. 
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CHAPTER 2 MATERIALS AND METHODS 
2.1 Plan of this chapter 
This chapter is arranged according to the following schedule: 
Basic procedures: 
1) Animals used in this project 
2) Preparation of toxin solutions 
3) Administration of toxin into the vitreous chamber of the animals 
4) Processing of the retina 
Specific experiments:‘ 
5) Study on the general effects of toxins 
- t i m e course study on retinal thickness 
一 - t i m e course study on pathological changes 
- d o s a g e study on TCS 
6) Study on cell death -
7) Study on the entry of toxins into cells 
8) Study on the reactions of retinal glial cells 
The first four items are the basic procedures of this project and the following four are the 
methods of the series experiments that are designed to investigate different problems. 
2.2 Toxins and methods used 
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Toxins 
1) Ribosome-inactivating proteins (RIPs) studied: this project studies mainly two of 
the type I RIPs, namely trichosanthin (TCS) and ricin A chain (RTA); a type II 
RIP, ricinus communis agglutinin (RCA), was also studied for comparison. 
2) Conjugation of fluorescein isothiocyanate (FITC) to type I RIPs: FITC-TCS and 
FITC-RTA were produced for tracing of the toxins. 
Methods 
1) Paraffin, cryostatic and electron microscope sections were prepared. 
2) Hematoxylin-and-eosin method was used to stain paraffin sections for 
observation on the general effects of RIPs. 
3) Terminal transferase-mediated nick-end labeling (TUNEL) was used to 
characterise the nature of cell death. 
4) Immunohistochemistry of activated caspase-3 was also used to characterise the 
nature of cell death. 
5) Electron microscopy was used to characterise and confirm the nature of cell 
death. 
6) Confocal microscopy on sections of retinas treated with fluorescein-toxin was 
used to investigate the entry mechanism of toxins into cells. 
7) Immunohistochemistry of glial cells and fluorecence labeling was used to study 
glial reactions to RIP intoxication. 
2.3 Animals 
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Young adult female Sprague-Dawley (S.D.) rats of about two months old, weighing 
180 - 200 grams, were used. They were obtained from the animal house of our 
university, maintained in clean plastic cages and subjected to standard light-dark cycles 
of 12 hours. All procedures conformed to the Animal (Control of Experiments) 
Ordinance of Laws of Hong Kong and the experiments have been approved by the 
Animal Research Ethics Committee of The Chinese University of Hong Kong. 
2.4 Preparation of toxin solutions 
Two of the type I RIPs, namely TCS and RTA, and a type II RIP, RCA, were used. The 
conjugates of FITC to type I RIPs (TCS and RTA) were produced. These toxins and 
conjugates were injected separately, one into each experiment rat; the right eye was 
injected. Sterile 0.86% physiological saline or pure FITC solution was injected into the 
left eye, which served as controls. 
2.4.1 RIP solutions 
Trichosanthin (TCS), ricin A chain (RTA) and ricinus communis agglutinin (RCA) (all 
from Sigma, U.S.A.) were separately dissolved and diluted in sterile 0.86% -
- physiological saline at different concentrations just before use. 
2.4.2 Labeling type I RIPs with fluorescein 
FITC (Pierce, U.S.A.) was conjugated to the type I RIPs TCS and RTA (Muramoto et al 
1984). The fluorescent label was used to indicate the location and movement of the toxin 
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molecules. The protocol for making FITC-TCS conjugate is given below. The same 
protocol was use to make FITC-RTA conjugate. 
Dialysis of TCS. A Slide-A-Lyzer Dialysis Cassette (Pierce, U.S.A.) was hydrated for 2 
minutes in O.IM carbonate/bicarbonate conjugation buffer (pH 9.5). 1 ml of diluted TCS 
at the concentration of 1 mg/ml in the conjugation buffer was injected into the cassette 
with a 2.5 ml syringe and 18-gauge needle. The syringe was rinsed with another 1ml of 
the conjugation buffer, which was subsequently injected into the cassette followed by 
removing all of the air from it. The cassette was then left in a 2-liter conjugation buffer 
(pH 9.5) at 4�C with stirring overnight for dialysis. 
Labeling FITC to TCS. In the following day, all TCS solution was removed from the 
dialysis cassette by a syringe. FITC powder was dissolved at the concentration of 200 jig 
/ 200|LL1 in the conjugation buffer (pH 9.5) and immediately added to the dialyzed TCS 
solution at the volume ratio of 200 [i\ FITC: 1 ml dialyzed TCS. The mixture was 
incubated at 37°C in the dark overnight. 
Dialysis of the FITC-TCS conjugate. In the following day, all the FITC-TCS conjugate 
solution was transferred to a new dialysis cassette, which was kept in a 2-liter 0.0IM 
phosphate-buffered saline (PBS, pH 7.2-7.4) at 4 � C in the dark with stirring overnight. 
Measuring and concentrating the conjugate. In the last day, all the dialyzed conjugate 
solution was removed out from the cassette. A sample of the solution was diluted 100 
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times. The absorbance of the diluted solution at the wavelength of 495 nm (A495) for 
FITC and 280 nm (A280) for TCS protein was read from the UV spectrophotometer. 
The F/P molar ratio of FITC/Protein conjugate was calculated as follows, where 2.77 
and 0.32 were correction factors: 
Molar F/P = (2.77 x A 4 9 5 ) -r (A280 - (0.32 x A 4 9 5 ) ) 
The concentration of the labeled proteins was calculated as follows, where 72,000 was 
the approximate molar extinction coefficient of FITC at 495 nm: 
Protein concentration (M) = ( A 4 9 5 x dilution factor) + (72,000 x Molar F/P) 
The initial concentration of the conjugate was too low for in vivo use, so it had to be 
concentrated. The entire conjugated sample was transferred to a centrifugal filter-and-
tube assembly (lOK NMWL Membrane 4ml VOL，Biomax, U.S.A.). It was centrifuged . 
with a No.809 rotor at 4°C, 3900 rpm for 15 minutes. The procedure was repeated until 
the required concentration was obtained. Finally, the conjugate was transferred to a 
small centrifuge tube and stored at 4°C in dark. 
2.4.3 Control solutions 
In the experiments using unconjugated toxins, 0.86% physiological saline was used as 
the control solution. The solution was sterilised with an autoclave. When cooled, the 
saline was refilled to its original volume with autoclaved double distilled water. 
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Subsequently, the sterile saline was aliquot into autoclaved centrifuge tubes and store at 
4�C. 
In the experiments using the FITC-conjugated toxins, pure FITC solution was used as 
the control. The FITC powder was first dissolved in O.IM carbonate/bicarbonate 
conjugation buffer (pH 9.5) at the concentration of 200 |ig/200 The solution was then 
divided into aliquots and stored at -20°C in the dark. The concentration of FITC was 
adjusted with sterile 0.86% saline just before injection. 
2.5 Administration of solutions 
All experimental and control solutions were injected into the vitreous chamber of the eye. 
2.5.1 Basic procedures of vitreous chamber injection 
Rats were anesthetized with an intraperitoneal injection of 7% chloral hydrate (0.5 
ml/100 g body weight). Solutions at different dosages were injected into groups of S.D. 
rats. Under a stereoscopic microscope, the toxin solution was injected into the right 
vitreous chamber with a 10 jil Hamilton syringe following a puncture by a 25-gauge 
needle about 1 mm behind the temporal limbus (Frasson et al 1999; Laabich et al 2000). 
To avoid injuring the lens, the needle of the Hamilton syringes was ground blunt before 
the operation. The eyes were cleaned with gauze soaked with sterile saline. The 
contralateral eye was injected with sterile 0.86% saline to control for the physical effects 
of the experimental manipulation (Frasson et al 1999). For each injection, 4 |il of the 
toxin or control solution was slowly injected into each eye over a duration lasting about 
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1 minute (Laabich et al 2000). The injected animals were allowed to survive for different 
time periods. Only one single injection was administered to each eye. 
2.5.2 Injection of trichosanthin (TCS) 
TCS solutions at 4 different dosages were injected. The animals were allowed to survive 
for different time periods. The scheme was as follows: 
Dosage (nmol) Survival period (days) Number of animals (n) Sections 
0.01 4 3 paraffin 
7 3 paraffin 
0.46 28 6 paraffin 
0.92 1 5 paraffin 
3 cryostatic 
2 3 paraffin 
3 cryostatic 
3 5 paraffin 
3 cryostatic 
4 3 paraffin 
3 cryostatic -
3 EM 
5 3 paraffin 
6 3 paraffin 
7 5 paraffin 
28 6 paraffin 
1.84 28 5 paraffin 
A total of 65 rats were used in this project. 
2.5.3 Injection of ricin A chain (RTA) 
RTA solutions at 4 different dosages were injected. The rats were allowed to survive for 
different time periods. The scheme was as follows: 
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Dosage (nmol) Survival period (days) Number of animals (n) Sections 
0.01 1 5 paraffin 
3 cryostatic 
2 3 paraffin 
3 cryostatic 
3 EM 
3 5 paraffin 
3 cryostatic 
4 3 paraffin 
5 3 paraffin 
6 3 paraffin 
7 5 paraffin 
0.02 7 3 paraffin 
0.04 7 3 paraffin 
0.07 7 3 paraffin 
A total of 48 animals were used in this project. 
2.5.4 Injection of ricinus communis agglutinin (RCA) 
Similarly, RCA solutions were injected as follows: 
Dosage (nmol) Survival period (days) Number of animals (n) Sections 
0.01 1 5 paraffin 
2 3 paraffin 
3 5 paraffin 
4 3 paraffin 
5 3 paraffin 
6 3 paraffin 
7 5 paraffin 
0.02 7 3 paraffin 
0.04 7 3 paraffin 
0.08 7 3 paraffin 
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A total of 36 rats were used in this experiment. 
2.5.5 Administration of FITC-TCS 
The concentration of the FITC-TCS was 3.69 mg/ml (130 |iM). This was injected into 
the right eye without any further dilution. Therefore the dosage for each injection was 
0.52 nmol FITC-TCS in 4 [il Pure FITC solution was used for the control. Since the 
molecular ratio of FITC to TCS was 6，the dosage for pure FITC injection was 6 folds 
that of the FITC-TCS injection. Hence, 4 \x\ of FITC solution at 0.30 mg/ml (3 nmol or 
1.2 |j.g) was injected into the contralateral (left) vitreous chamber. The animals were 
allowed to survive for 1, 2, 3 and 4 days separately. Three rats were used for each of 
this time point (n = 3). All tissues were processed for cryostatic sections. 
2.5.6 Administration of FITC-RTA 
The concentration of the FITC-RTA was 0.08 mg/ml (2.5 |iM). This was injected into 
the right eye without any further dilution.-Therefore the dosage for each injection was 
0.01 nmol FITC-RTA in 4 \il Pure FITC solution was used for the control. Since the 
molecular ratio of FITC to RTA was 4，the dosage for pure FITC injection was 4 folds 
that of the FITC-RTA injection. Hence, 4 |ll1 of FITC solution at 0.004 mg/ml (0.04 
nmol or 0.016 |ig) was injected into the contralateral (left) vitreous chamber. The rats 
were allowed to survive for 1，2 and 3 days separately. Three rats were used for each of 
the time points (n = 3). All tissues were processed for cryostatic sections. 
2.6 Retinal tissue processing 
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At different times after the injection, the retinas were processed separately for one of 
these methods: paraffin, cryostatic and electron microscopic (EM) methods. 
2.6.1 Paraffin method 
Rats were anesthetised with chloral hydrate and were subjected to intracardiac perfusion 
as follows. The heart was exposed, and an incision was made on the right auricle to 
allow the escape of blood and the perfusion fluid. Immediately, an 18-gauge needle 
connected to a bottle of 0.86% saline was inserted into the left ventricle of the heart. 
When the effluent through the right auricle was clear of blood, the perfusion fluid was 
changed to a fixative of 4% paraformaldehyde in 0.1 M phosphate buffer at pH 7.4 
(PFA). Cold saline and PFA (both at 4�C) were used for better tissue preservation. Full 
extension of the hind limbs, and stiffening and turning pale of the muscles indicated 
complete fixation. The temporal pole of each eye was marked with a small cut at the 
sclera. The eyes were removed. The inferior half of the cornea was cut away and the 
lens was removed. The posterior three-quarter of the eyeball was further fixed in the 
same fixative overnight at 4�C (Daugeliene et al 2000). In the following day, the eyes 
were dehydrated in 70%, 80% and 95% alcohol for one hour each and in three changes 
of absolute alcohol for 20 minutes each. Then they were immersed successively in two 
changes of xylene and four changes of paraffin, all for 20 minutes each. Afterwards, the 
eyes were embedded in paraffin. Each eye was sectioned along the sagittal plane to 
produce 4 jim-thick sections; only those sectioned through the optic disk were mounted 
onto slides (Ranchon et al 2001). The sections for H&E staining were mounted onto 
precleaned plain slides, while those for other reactions were mounted onto 
SuperFrost®Plus slides (Gerhard Menzel, Germany). All slides were dried on a warm 
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plate and then left to desiccate in a 50°C oven overnight. They were stored at room 
temperature. 
2.6.2 Cryostatic method 
Rats were anesthetised and perfused in the same way as for the paraffin method (2.6.1). 
The posterior three-quarter of the eyeball was further fixed also in the same way. In the 
following day, the eyes were placed in the following sucrose solutions in 0.1 M 
phosphate buffer at pH 7.4: 10% and 20% sucrose solutions for 2 hour each in room 
temperature, and then 30% solution overnight at 4°C. Then the eyes were embedded in 
O.C.T. compounds (Sakura Finetek, U.S.A.) and cut sagittally with a cryostat to produce 
20 |im thick sections. Only those sections containing the optic disk were obtained. They 
were mounted onto slides coated with 3% gelatin. After drying at room temperature 
overnight, the slides were collected and stored at -70 
For eyes injected with fluoresceins or fluorescein-toxin conjugates, care was taken to 
avoid their exposure to light during the processing. 
2.6.3 Electron microscopic method 
Under anesthesia, rats were perfused as above (2.6.1). The eyes were removed and 
immediately immersed in 2.8% glutaraldehyde and 1.8% paraformaldehyde in 0.1 M 
phosphate buffer (PB) at pH 7.4 on ice with shaking for six hours. The cornea and lens 
were removed and rinsed in a mammalian Hepes buffer at pH 7.2. The Hepes buffer was 
made up of 140 mM NaCl, 30 mM Hepes, and 5 mM CaCh, The eyes were then 
immersed in 0.2 M sodium cacodylate in 4% sucrose on ice overnight. In the following 
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day, the eyes were cut into blocks at 1 mm wide and 5 mm long with the optic nerve 
remaining at the central sides of the blocks; the whole thickness included the retina, 
choroid and sclera. The blocks were post-fixed in 1% osmium tetroxide for 2 hours at 
room temperature. They were rinsed in distilled water and cacodylate buffer for several 
times, dehydrated in a graded series (20%-100%) of ethanol and then in propylene oxide, 
infiltrated with Epon 812, and finally polymerized in pure Epon 812 for 48 hours at 65 
•C. Ultra-thin sections were cut on an ultramicrotome (Reichert-Jung) using diamond 
knives, collected on copper grids, and stained with 4% uranyl acetate and Reynolds lead 
citrate. The sections were observed with a Hitachi H7100 transmission electron 
microscope at 75kV. 
2.7 General effects of RIPs on retina 
The RIPs injected retinal paraffin sections, including those treated with trichosanthin 
(TCS), ricin A chain (RTA) and rcinus communis agglutinin (RCA), were stained with 
hematoxylin-and-eosin (H&E) and observed under the light microscope. Morphological 
and histological features were studied. A series of quantity data were collected and 
statistically analysed. . 
2.7.1 Hematoxylin-and-eosin staining 
The slides were dewaxed and rehydrated in three changes of xylene and one change each 
of the graded alcohols (100%, 95%, 80% and 70%). They were then washed in tap 
water. The slides were stained in hematoxylin for 3 minutes when the nuclei became 
purple, differentiated in acid alcohol and Scott's (define) tap till the nuclei became blue, 
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and then stained in eosin for 10 minutes. Between these steps the slides were well rinsed 
in tap water. The slides were dehydrated in graded alcohols (70-100%), cleared in 
xylene and mounted with Permount. 
2.7.2 Retinal thickness 
Retinal thickness was measured to quantify possible swelling or shrinking after the toxin 
treatment. 
TCS-injected retinas. The retinal thickness was measured at 1, 3，7 and 28 day after 
injection of 0.92 nmol TCS solution (n = 5 for each time point, see 2.5.2). Three 
sequential median sagittal sections made through the optic disc were use for measuring 
the retinal thickness (Morizane et al 1997; Mizuno et al 2001). The interval among the 
sections was 12 |Lim. The thickness was measured at four sites of each section: 0.5 mm to 
the superior and inferior ora serratae representing the peripheral part, and 0.5 mm 
inferior to and superior to the borders of the optic nerve representing the central part. For 
each eye, an average was obtained from the six peripheral measurements on the three 
sections, and an average was obtained from the six central measurements on the same 
three sections (Tsujikawa et al 1998; Ranchon et al 2001). The percentage change in 
thickness after the treatment was calculated as: (thickness of experimental eye -
thickness of control eye) + thickness of control eye x 100%. 
RTA-injected retina. The retinal thickness was measured at 1, 3, 7 day after injection of 
0.01 nmol RTA solution (n = 5 for each time point, see 2.5.3). The retinal thickness was 
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measured, and the percentage change in thickness calculated in the same way as 
described above for the TCS-treated retinas. 
RCA-injected retina. In the time course study of RCA, the retinal thickness was 
measured at 1，3 and 7 day after 0.01 nmol RCA injection (each group, n = 5)，which 
matched the dose and time periods of RTA. The retinal thickness was measured and the 
percentages of the changes in thickness calculated in the same way as described above 
for the TCS-treated retinas. 
2.7.3 Pathological changes 
The severity of retinitis was determined by a semi-quantitative histopathologic scoring 
system, which was based on the previous studies (Cousins et al 1989; Brandt et al 1997) 
with slight modifications. The eyes injected with 0.92 nmol TCS, 0.01 nmol RTA, 0.01 
nmol RCA at 1, 3 and 7 day post-injection were evaluated (n = 5 for each group, see 
2.5.2 to 2.5.4). The retinas were sampled in the same manner as for measuring retinal 
thickness - two peripheral and two central regions in three sequential median sections of 
each eye were examined. Three features at each area, namely vitreous infiltrate, retinal 
cytology and retinal inflammation, were evaluated using the following scheme. The 
evaluation was made at x400 magnification under the light microscope. 
Scores for cellular infiltration of the vitreous chamber. Inflammatory cells were 
counted within the field of observation under the microscope. Scores were: 0-none; 1-
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less than 10 cells; 2-10 to 100 cells; 3—more than 100 cells, or epithelioid cell 
predominance; 4—organizing vitreous membrane. 
Retinal cytology. Cellular morphology was recorded. Scores were: 0-normal; 1-
possible vacuolization or cystoid change; 2-definite vacuolization, cystoid change or 
nuclear degeneration; 3 - total loss of morphology. 
Scores for retinal inflammation. Scores were: 0-no inflammatory leukocyte; 1-mild 
infiltration or less than 10 inflammatory cells; 2-marked infiltration, or 10 or more 
inflammatory cells with preservation of retinal structure; 3-marked infiltration with 
some loss of architecture; 4-obliteration of normal retinal structure. 
2.7.4 Dosage study on TCS 
This was carried out using only TCS. Four dosages were used: saline controls (n = 6)， 
0.46 nmol (n = 6), 0.92 nmol (n = 6) and 1.84 nnol (n = 5) (see 2.5.2). The animals were 
kept for 28 days. Three sequentially median sagittal sections of each eye, cut through the 
optic disc, were examined. Computer images of the four sites (see 2.7.2) of each section 
were taken using Metamorph Imaging System (Universal Imaging Corporation, U.S.A.) 
at x400 magnifications (Cheng & Tam 2000; Nakagawa et al 2000). On each image, 
cells in the ganglion cell layer (GCL), inner nuclear layer (INL) and outer nuclear layer 
(ONL) were counted using Stereo Investigator (MicroBrightField, Inc., U.S.A.), which 
allowed unbiased sampling (Frasson et al 1999). Morphologically distinguishable 
vascular endothelial cells and astrocytes were excluded from the counting (Lam et al 
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1999; Mizuno et al 2001). Each image spanned 350 陣 of the section. The data 
represented cell numbers within this length of the GCL, INL, and ONL. 
2.7.5 Statistics 
All data were presented as mean 土 SEM with a minimum of n=5. The data were 
analyzed using GraphPad InStat (Graph Pad Software, Inc., U.S.A.) and MINITAB 
(Minitab, Inc., U.S.A.) software. The differences were analyzed by t test, p < 0.05 was 
considered to indicate statistical significance of the test result (Mizuno et al 2001). 
2.8 Mechanisms of cell death 
Cell death is generally characterised as necrosis or apoptosis. The following methods 
were used for such characterisation: 
2.8.1 Terminal dUTP nick-end labeling (TUNEL) 
Apoptotic cell death was detected by TUNEL (Hara et al 1999; Yew et al 2001). Two 
kinds of apoptosis detection kits (Intergen, U.S.A. and Boehringer, U.S.A.) were applied 
following the manufactures' protocols. At different times after the treatment with RIPs 
- (TCS, RTA and RCA), the retinas were prepared for paraffin sections. The sections 
were reacted with the TUNEL methods for fluorescence and bright-field study. 
For fluorescence study, the dewaxed and rehydrated sections were rinsed with 0.01 M 
phosphate buffered saline (PBS) at pH 7.4’ digested with 20|ig/ml proteinase K (Sigma, 
U.S.A.) for 15 minutes, and then incubated with the mixture of terminal 
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deoxynucleotidyl transferase (TdT) and fluorescein isothiocyanate (FITC) at the ratio of 
1： 9 at 37°C for one hour in a dark humid chamber. They were washed in PBS, and then 
reacted with 10 |j.g/ml propidium iodide (PI) for 1 minute in the dark for contrastaining. 
The slides were finally mounted with glycerol and immediately observed under the laser 
confocal microscope (for details of confocal microscopy, please refer to 2.9.3). 
For bright-field study, the sections were digested with 20 ！ig/ml proteinase K for 15 
minutes and treated with equilibration buffer for 5 minutes (3% H2O2 treatment was 
omitted from the protocol). Then the sections were incubated with terminal 
deoxynucleotidyl transferase (TdT) at half of the concentration recommended by the 
manufacturer at 37°C for one hour in a damp container. The reaction was stopped in the 
stop/wash buffer for 10 minutes. The sections were incubated with anti-digoxigenin 
antibody at room temperature for half hour followed by staining with nickel ammonium 
sulfate-added 3’3，-diaminobenziciine (DAB) solution (please refer to appendix F). 
Finally, the sections were dehydrated and mounted with Permount, and then observed 
under a light microscope. 
To control for possible experimental errors, sections known to contain a high density of 
apoptotic cells were processed at the same time as the experimental sections. Retinas of 
4-week old Royal College of Surgeons (RCS) rats were used as such a positive control 
(Katai et al 1999; Yu et al 2000). For negative control, the TdT enzyme was substituted 
by O.OIM PBS, or by FITC solution for fluorescence study. 
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2.8.2 Immunohistochemistry for caspase-3 
Eyes were injected with 0.92 nmol TCS or 0.01 nmol RTA (see 2.5.2 and 2.5.3). 
Cryostatic sections were prepared from the eyes after different survival periods, and 
were processed with an immunohistochemical method of activated (proteolytically 
cleaved) caspase-3. Caspase-3 is the most prevalent caspase in the cell and is 
immediately responsible for bringing about nuclease-induced DNA fragmentation. 
Sections were washed with 0.01 M PBS three times for 10 minutes each, immersed with 
10% normal horse serum (NHS) in 0.01 M PBS at pH 7.4 for half hour to block 
endogenous immunoreactivity, and then incubated with 1:100 polyclonal rabbit anti-
cleaved-caspase-3 primary antibody (Cell Signaling Technology, Inc. MA, U.S.A.). The 
antibody had been diluted in 0.01 M PBS containing 0.5% NHS and 0.5% Triton X-100 
(Sigma, U.S.A.). The incubation was carried out at room temperature in a humid 
chamber overnight. Then the sections were washed in PBS three times for 10 minutes 
each, followed by reaction with 1:400 Cy3-conjugated anti-rabbit secondary antibody 
(Jackson ImmunoResearch Laboratories, Inc. PA, U.S.A.) for two hours in a dark moist 
chamber. Finally, the sections were rinsed with PBS, mounted in glycerol, and observed 
under the confocal microscope. 
2.8.3 Double staining of cleaved caspase-3 and TUNEL 
The cryostatic sections were first reacted with the anti-cleaved-caspase-3-primary 
antibody and then with CyS-conjugated secondary antibody as above. Subsequently, the 
sections were incubated with a mixture of TdT and FITC at 37°C for one hour in the 
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dark (see 2.8.1) according to the protocol of Fluorescein TUNEL Kit. The slides were 
mounted with glycerol and observed under the confocal microscope immediately. 
2.8.4 Electron microscope observation 
Ultrastructural changes are reliable clues on apoptotic changes. Eyes were injected with 
0.92 nmol TCS and processed 4 days later, or with 0.01 RTA and processed 2 days later 
(see 2.5.2 and 2.5.3). The ultrathin sections were observed under a Hitachi H7100 
transmission electron microscope at the voltage of 75kV for signs of apoptotic and 
necrotic changes. Photographs were taken at 2,000 and 5,000 magnification. 
2.9 Entry of type I RIPs into cells 
To study the entry (uptake) mechanism of type I RIPs into cells, FITC-conjugated TCS 
or RTA were injected into the vitreous chamber. The TCS-injected rats were kept for 1 
to 4 days, and the RTA-injected rats for 1 to 3 days (see 2.5.5 and 2.5.6). Cryostatic 
sections of the retinas were cut at 20 \im thickness and were processed with the 
following methods. 
2.9.1 Propidium iodide staining 
Propidium iodide (PI) stains double stranded nucleic acids. Cryostatic sections were 
washed in 0.01 M PBS three times for 10 minutes each, and then reacted with PI at the 
concentration of 10 |j.g/ml for one minute in the dark. Then they were washed in PBS 
three times for 5 minutes each, mounted with glycerol and immediately examined under 
the confocal microscope. The green filter of the confocol microscope allowed detection 
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of the FITC-TCS or FITC-RTA，and the red filter for detection of PI stained nuclei. The 
location of the toxins with respect to the nucleus could therefore be determined. 
2.9.2 Immunohistochemical localization of Miiller cells 
Cryostatic sections were washed with three changes of 0.01 M PBS for 10 minutes each, 
immersed in 10% normal horse serum for half hour to block endogenous 
immunoreactivity, and then incubated in 1:500 mouse anti-glutamine synthetase (GS) 
monoclonal antibody (Chemicon International, Inc. CA, U.S.A.) at room temperature 
overnight. After washing in PBS, the sections were incubated with 1:400 Cy3-
conjugated anti-mouse secondary antibody (Jackson ImmunoResearch Laboratories, Inc. 
PA, U.S.A.) for two hours in the dark. Finally, the sections were mounted in glycerol 
and observed under the confocal microscope. 
2.9.3 Double staining of Miiller cells and TUNEL 
Paraffin sections of eyes injected with 0.92 nmol TCS were used. The rats were kept for 
3 days (see 2.5.2). The sections were first reacted with the above 1:500 mouse anti-
glutamine synthetase monoclonal antibody over night followed by 1:400 Cy3-
conjugated anti-mouse secondary antibody for two hours. Then they were incubated 
with a mixture of TdT and FITC at 37�C for one hour in the dark. The slides were 
mounted with glycerol and observed under the confocal microscope immediately. 
2.9.4 Confocal microscopy 
Under the confocal microscope (MRC 1024，BioRad), the sections were excited by 
krypton/agron laser. The signals of FITC-labeled trichosanthin and ricin A chain were 
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detected by the preset FITC channel with excitation at 494 nm and emission at 520 nm. 
The signals of propidium iodide were detected by the preset Texas red channel with 
excitation at 596 nm and emission at 615 nm. The signals of glutamine synthetase were 
identified by the preset Cy3 channel with excitation at 550 nm and emission at 570 nm. 
The images in different channels were captured and merged when needed to investigate 
different problems by the software LaserShop 2000. 
2.10 Reactions of glial cells 
Immunohistochemistry for Muller cells and asctrocytes 
Paraffin sections of eyes injected with 0.92 nmol TCS, 0.01 nmol RTA and 0.01 nmol 
RCA were used. The rats were kept for different time periods (see 2.5.2 to 2.5.4). 
Briefly, the sections were dewaxed and rehydrated followed by blocking unwanted 
background activity with 10% normal horse serum for half an hour. Subsequently, the 
sections were incubated in a humid chamber at room temperature overnight either with 
1:500 mouse anti-glutamine synthetase (GS) monoclonal antibody for staining Miiller 
cells or with 1:400 mouse anti-glial fibrillary acidic protein (GFAP) monoclonal 
antibody for staining astrocytes (both antibodies from Chemicon International Inc., CA, 
U.S.A,). In the following day, Cy3-conjugated anti-mouse secondary antibody was 
applied to the sections, which were incubated for two hours at room temperature in the 
dark. The sections were mounted in glycerol and at once observed under a fluorescence 
microscope. The images were recorded with a SPOT cooled color digital camera 
(Diagnostic Instruments, Inc., U.S.A.) and software Metamorph (Universal Imaging 
Corporation, U.S.A.). 
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FITC-GS-I-B4 for microglia 
Paraffin sections of eyes injected with 0.92 nmol TCS, 0.01 nmol RTA and 0.01 nmol 
RCA were used to study the reactions of microglia. The rats were kept for different 
survival days (see 2.5.2 to 2.5.4). The sections were dewaxed, rehydrated, and 
incubated with FITC conjugated Griffonia simplicifolia lectin I isolectin B4 (GS-I-B4) at 
the concentration of 20 L^g/ml (Sigma, U.S.A.) in a dark humid chamber at room 
temperature overnight. The sections were then counterstained with PI at the 
concentration of lOp-g/ml for 1 minute, mounted in glycerol and observed under the 
confocal microscope. 
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CHAPTER 3. RESULTS 
3.1 Preparation of fluorescein-type I RIP conjugates 
Type I ribosome-inactivating proteins (RIPs) including trichosanthin (TCS) and ricin A 
chain (RTA) were conjugated with fluorescein isothiocyanate (FITC). Samples of the 
resulted conjugates, diluted 100 times, were read with a spectropotometry and the 
concentrations of the conjugates were calculated. 
3.1.1 Conjugate of FITC-TCS 
The absorbances of the FITC-TCS sample were 0.110 at 495 nm and 0.086 at 280 nm; 
therefore the molecular ratio of FITC to TCS was 6.00 and the concentration of the 
conjugate was 25.5 |J,M (0.66 mg/ml). After centrifugation, the concentration of the 
conjugate was 130 \iM (3.69 mg/ml); this contained 0.52 nmol TCS in every 4 
conjugate solution. 
3.1.2 Conjugate of FITC-RTA 
The absorbances of the FITC-RTA sample were 0.008 at both 495nm and 280 nm; 
therefore the molecular ratio of FITC to RTA was 4.07 and the concentration of the 
conjugate was 2.5 |iM (0.08 mg/ml). This contained 0.01 nmol RTA in every 4 |il 
conjugate solution. 
3.2 Effects of TCS on retina 
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Rats were injected with different doses of TCS at the vitreous chamber, and kept for 1 to 
28 days. The eyes were then processed and sections were stained with H&E for general 
morphological observations. 
A single dosage of 0.92 nmol of TCS was found to have effectively killed retinal cells at 
one week after the injection. This dose was used for the time-course study on retinal 
thickness and pathological changes. 
From the results on time-course study, it was found that general tissue and glial reactions 
had almost subsided at one month after the injection. It was decided the dose-
dependence study of retinal cell counts be carried out on rats given a one-month survival _ 
period. 
3.2.1 Retinal cell count - a dose-dependence study 
Three different doses of TCS, 0.46 nmol (n=6), 0.92 nmol (n=6) and 1.84 nmol (n=5) 
were used for TCS dose-dependence study. The control group (n=6) was injected with 
sterile 0.86% saline. Cells in the three layers of retina, the ganglion cell layer (GCL), 
inner nuclear layer (INL) and outer nuclear layer (ONL), at both peripheral and central 
retinal regions, were counted separately one month after the injection. 
There was a similar pattern of change in cell number at both the peripheral and central 
regions (Figs. 1 and 2). At both sites, the ONL cells decreased quickly with the increase 
in dosage (p<0.01, both regions). In the INL layer, the effect of TCS was also significant 
(pcO.Ol，both regions), but the cell number decreased much more slowly than those in 
- 4 8 -
ONL. The results showed that TCS was more toxic to ONL cells than to INL cells. 
(Table 1 and Graphs 1 and 3). In either of these two retinal layers, the decrease in cell 
number was significantly larger in the central retina than the peripheral retina (p<0.01) 
(Table 1 and Graphs 1 and 2). These results showed that (i) ONL cells were the most 
susceptible retinal cells to TCS intoxication; and (ii) the central retina was more 
sensitive to TCS intoxication than the peripheral retina (Table 1 and Graphs 1 and 2). 
The effect of TCS on GCL cells at the two sites was not obvious; statistically significant 
difference existed only between the control and the highest dose group (1.84 nmol) at 
both retinal sites (both p<0.05) (Table 1 and Graph 1). 
3.2.2 Retinal thickness measurement - a time-course study 
The dose of TCS for each injection was 0.92 nmol. The survival periods were 1，3，7 and 
28 days (each group n=5).'The peripheral and central regions showed similar changes in 
retinal thickness with time. Compared with the retina on the control side, the TCS-
treated retina increased in thickness by 8.0+3.4% at the peripheral retina and by 
7.8土 1.3% at the central retina one day after the injection (Fig. 3a to 3d). Three days 
after the injection, the increase was 4.0土2.0% at the periphery and 0.3+0.8% at the 
centre (Fig. 4a to 4d). One week after the injection, the TCS retinal thickness had 
decreased instead, by 22.0土4.3% at the periphery and 25.4+3.3% at the centre (Fig. 5a to 
5d). One month after the injection, the change in thickness was similar to that at one 
week, being a 21.2+5.0% decrease at the periphery and 25.4+3.3% at the centre (Table 2 
and Graph 4). 
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The increase in thickness in both regions at 1 and 3 day after TCS treatment was not 
statistically significant (both p>0.05). However, the decrease observed at 1 week and 1 
month was statistically significant (both p<0.01). 
At both the peripheral and central retinas, the change in retinal thickness was not 
statistically different between the 1-day and 3-day groups; neither was there any 
difference between the 1-week and 1 -month groups. However, there was a significant 
difference between the 3-day and 1-week groups at both retinal regions (both pcO.Ol)’ 
This suggested that the decrease occurred mainly between 3 day and 1-week post-
injection. At any time point, there was no significant difference in the change in 
thickness between the peripheral and central regions (p>0.05). 
3.2.3 Pathological changes 
Inflammatory change, or retinitis, was assessed by the scoring system of Cousins et al 
1989; Brandt et al 1997 (see Methods 2.7.3). Eyes injected with 0.92 nmol of TCS were 
assessed. The scores at three time-points' for the peripheral and central retinal regions 
were given in Table 6. The scores on the three pathological parameters - vitreous 
infiltrate, retinal cytology, and inflammation, did not show any significant change with 
time, or any significant difference between the two retinal regions (Figs. 3 to 5, Tables 6 
to 9 and Graph 8). 
On comparison, there was no significant difference between the control and TCS-
injected groups at each time-point and retinal location (Tables 7a, 8a and 9a). This 
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suggested that TCS at a dosage that effectively reduced the cell numbers, produced little 
inflammatory reaction of the retina. 
3.3 Effect of RTA on retina 
A pilot dose-response study was carried out to find out the optimal dose of RTA for 
experimentation. Based on the present results from the TCS experiments, a survival 
period of one week was allowed. H&E-stained sections were prepared. At 0.07 nmol of 
RTA, the retinal structure was extensively damaged and no retinal cell layers could be 
identified (Fig. 6). At about half of the dosage, the structure was similarly destroyed. At 
0.02 nmol, the retinas appeared less damaged. Even at a dose reduced to 0.01 nmol, the 
adverse effect was still significant (Fig. 6d). At this dosage, obvious cell infiltrate and 
capillary enlargement could be observed, but the overall retinal layer architecture was 
preserved, and the neuronal population persisted. Hence the dose of 0.01 nmol was used 
for the time-course study of RTA. 
3.3.1 Retinal thickness measurement - a time-course study 
Retinal thickness was studied at 1，3, and 7 day post-injection. The peripheral and 
central regions showed similar changes in retinal thickness with time. 
On comparing with the ret4na on the control side, the RTA-treated retina was found to 
have increased in thickness by 11.0+2.0% at the periphery, and by 20.7土 1.9% at the 
centre，at 1 day after injection. Three days after injection, the increase was 17.0+0.92% 
at the periphery and 20.7土0.7% at the centre. One week after the injection, the thickness 
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had decreased instead, by 14.6+2.3% at the periphery and 13.3+0.5% at the centre (Figs. 
6 and 7, Table 3 and Graph 5). The increase in thickness in both regions at 1，3 and 7 
day after the RTA treatment was statistically very significant (both p<0.01). These 
results differed from those for the TCS-treated retinas at the same time-points. 
At both the peripheral and central retinas, the change in retinal thickness was not 
statistically different between the 1-day and 3-day groups. However, there was a 
significantly difference between the 3-day and 1-week groups at both retinal regions 
(both p<0.01)，This suggested that the decrease occurred mainly between 3 day and 1-
week post-injection. These results were similar to those for the TCS-treated retinas. 
There was significant difference between peripheral and central retinas in the increase in 
retinal thickness at 1 day after RTA injection (p<0.01). This suggested that the central 
retina might be more sensitive to the effect of RTA than the peripheral. However, the 
changes at 3 and 7 day were similar between the two regions (both p�0.05) (Table 3). 
These results differed from those for the TCS-treated retinas, in which no significant 
difference was observed between the peripheral and central regions at any time point. 
Comparing with the TCS-induced swelling, that caused by RTA was significantly higher 
at 3 day post-injection at the periphery (p<0.05), and 1 and 3 day post-injection at the 
centre (both p<0.01) (Table 5，Graph 7). The results indicated that the retinal swelling 
caused by RTA was more severe than that caused by TCS, even the dose of RTA was 
only one hundred times lower (0.01 nmol) than that of TCS (0.92 nmol). 
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3.3.2 Pathological changes 
The scores for retinitis at three time-points for the peripheral and central retinal regions 
were given in Table 6. On comparison with the controls, except for the retinas at 1 day 
post-injection, the pathological parameters were all increased (Figs. 6d and 7 and Tables 
7a, 8a and 9a). 
There was a sharp increase in retinal inflammation between 1 and 3 day in both the 
peripheral and central retinas (both pcO.Ol) (Table 9b and Graph 8). These results 
showed that pathological changes became evident at 3 day post-injection, and of these 
changes, the retinal inflammatory responses was the most remarkable. There appeared 
to be signs of leveling off from 3 day onward. -
Regional difference. No difference was observed between the central and central retinas 
at any time points (Tables 7c, 8c and 9c). 
Comparison with other RIPs. Vitreous infiltrate of RTA-treated retinas was -
significantly higher than that of TCS-treated retinas at 7 day post-injection at both sites 
(pcO.Ol in all cases). Changes in retinal cytology were also more pronounced in the 
RTA group than the control or TCS groups at all times at both sites (p<0.05). Retinal 
inflammation was higher in the RTA group than in the control and TCS groups at 3 and 
7 day at both sites (pcO.Ol). Hence, RTA did cause marked retinitis, though TCS was 
found not. (See Tables 8a, 8b and 8c) 
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3.4 Effects of RCA on retinas 
The doses of ricinus communis agglutinin (RCA) used were similar with those of RTA, 
which were 0.08，0.04，0.02 and 0.01 nmol for each single injection of RCA. The rats 
were also allowed to survive for one week. The H&E-stained sections indicated that 
RCA produced effects similar to those of RTA. At 0.08 nmol, retinal structure was 
damaged and no retinal cell layers could be identified (Fig. 8). At half of this dose, the 
retinal architecture was similarly destroyed. At 0.02 nmol RCA, the retina appeared 
more intact. However, even when reduced to as low as 0.01 nmol, cell infiltration was 
still noticeable. Hence, as with RTA, 0.01 nmol of RCA was used for the time-course 
study of its effects. 
3.4.1 Retinal thickness measurement 
Retinal thickness was studied at 1，3，and 7 day post-injection. The peripheral and 
central regions showed similar changes in retinal thickness with time. 
Compared with the retina on the control side, the RCA-treated retina increased in 
. t h i c k n e s s by 7.6+1.3% at the periphery and by 17.6+2.3% at the centre at 1 day post-
injection. At 3 day post-injection, the increase was 12.7+3.3% at the periphery and 
21.3+4.2% at the centre. One week after the injection, the thickness had decreased 
instead, by 10.9土2.2% at the periphery and 11.8+1.4% at the centre (Figs. 8d and 9’ 
Table 4 and Graph 6). The differences from control values were significance in all 
cases (Table 4; p <0.01 in most cases). When compared with the TCS and RTA groups, 
significant difference only existed between the RCA and TCS groups at 3-day at the 
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centre (p<0.01) (Table 5 and Graph 7). Put together, the effects of RCA on retinal 
thickness were very similar with those of RTA but were much more severe than those of 
TCS. 
There was no significant difference between peripheral and central retinas in the 
increase in retinal thickness at each time point (all p>0.05) (Table 5, Graph 7). These 
results differed from those for the RTA-treated retinas, which showed significant 
difference between the two regions at 1 day. 
3.4.2 Pathological changes 
The scores for retinitis at the three time-points for the peripheral and central retinal 
regions were given in (Figs. 8 and 9，Table 6). On comparison with the controls, except 
for the retinas at 1 day post-injection, the pathological parameters were all increased 
(Tables 7a, 8a and 9a). 
In general, the time-course of RCA-induced changes was similar to those of RTA-
induced changes, except for vitreous infiltrate (Graph 8). There was statistically 
significant difference between the 1-day and 3-day time groups in both retinal cytology 
and retinal inflammation, at both the peripheral or central retinas (p < 0.05) (Tables 7b, 
8b and 9b). 
Regional difference. Significant difference existed between the peripheral and central in 
retinal cytology and retinal inflammation at 3 day (p < 0.05). This suggested that the 
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central retina was more sensitive to RCA than the peripheral retina (Tables 7c, 8c and 9c 
and Graph 8). 
Comparison with other RIPs. As shown above TCS did not appear to cause pathological 
changes to any significant extent, whereas RCA did. Hence statistical tests showed that 
there was significant difference between RCA and TCS groups, at three and seven day 
post-injection at both retinal regions. RCA basically did not differ significantly from 
RTA in inducing pathological changes (except for the cytology of peripheral retina at 1 
day). (See Tables 8a, 8b and 8c) 
3.5 Summary of results: general effects of RIPs 
TCS RTA RCA 
Cell ONL U ~ ^ ^ 
count INL 丄 
Retinal thickness l-3d No change T t ‘ t t 
Id 丄 vl W i i 
Retinitis score No change TT TT 
Specificity Yes No No 
� (ONL & INL) . 
3.6 Cell death - TUNEL method 
Eyes injected with TCS, RTA, RCA were processed after different survival periods with 
the TUNEL method. The TUNEL method stained the 3'-OH end of broken DNA 
strands, and since DNA fragmentation occurred during apoptosis, it indicated the 
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likelihood of apoptosis. Retinas of 4-week-old Royal College of Surgeons (RCS) rats 
were used for negative and positive control. 
3.6.1 TCS experiment 
Apoptotic cells were not detected in GCL and INL of the retinas of the RCS control rats. 
They were detected only in the ONL (Fig. 18b). 
Eyes of the experimental rats were injected with 0.92 nmol of TCS. The eyes were fixed 
and processed at 1,2, 3，4，5，6，7 and 28 day post-injection by the TUNEL method. At 1 
day, apoptotic signals began to be detectable mainly in INL (Fig. 10). Positives cells 
reached the highest number at 4 day; they were predominantly located in ONL; less 
were located in INL, and still less in GCL (Fig. 10). The signals became much weaker at 
7 day. At the 28 day, no positive signal was detected (Fig. 11). All saline-injected 
controls were negative in any period, and the negative RCS control, in which the TdT 
enzyme was omitted, was totally devoid of positive signals. 
TCS was also observed to induce necrotic cell death. Cells undergoing the different 
processes, apoptosis or necrosis, showed different morphology in TUNEL staining (Fig. 
12). Apoptotic cells had condensed nuclei, while necrotic cells had dark cytoplasm. 
Apoptotic cells were common, while the necrotic cells were only occasionally seen. 
At a low dosage (0.01 nmol), some TUNEL-positive cells could still be detected, but 
they were much fewer than at the higher dosages (Fig. 13). 
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3.6.2 RTA experiment 
Eyes of the experimental rats were injected with 0.01 nmol of RTA. The eyes were 
fixed and processed by the TUNEL method at daily intervals between 1 and 7 day post-
injection. At 1 day, some apoptotic signals were detected. The signal peaked at 2 to 3 
day (Fig. 14). At 7 day, the signals had become weaker (Fig. 15). The positive signals 
occurred in individual regions, where they scattered all over the retinal layers. The 
signals appeared to be higher in the inner retinal layers. This pattern was very different 
from that of TCS-treated retinas. 
3.6.3 RCA experiment 
Eyes of the experimental rats were injected with 0.01 nmol of RCA. The eyes were 
fixed and processed by the TUNEL method at daily intervals between 1 and 7 day post-
injection. At 1 day, some regionally localised apoptotic signals were detected. The 
signal peaked at 2 to 3 day (Fig. 16). At 7 day, the signals had become weaker (Fig. 17). 
This pattern was similar to that of RTA-treated retinas. 
3.7 Cell death - cleaved caspase-3 immunohistochemistry 
Cleaved caspase-3, the most common activated protein in the pathway of neuronal 
apoptosis, was investigated by immunohistochemistry using a monoclonal antibody; it 
was labeled by fluorochrome Cy3, which appeared red under the confocal or 
fluorescence microscope. Retinas of 4-week-old Royal College of Surgeons (RCS) rats 
were also studied. 
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Retinas of RCS rats. Positive cells (with red signals) were only detected in the ONL. 
The signals were located in the same layer as TUNEL positive (green) cells. Many of the 
red and green signals overlapped. The blue phase contrast image allowed better 
visualisation of the layers and hence facilitated localisation of the signals. (See Fig. 18.) 
3.7.1 TCS experiment 
Retinas treated with 0.92 nmol of TCS were examined at 1，2，3 & 4 day post-injection. 
At 1 day, cleaved casapse-3-positive (red) and TUNEL positives (green) cells were 
detected; they appeared overlapped (Fig. 19). Figure 19 showed a typical colocalisation 
of the two signals: positive TUNEL signal was located at the centre of the cell, where 
the condensed nucleus was probably located, surrounded by positive cleaved caspase-3 
signal. Both caspase-3 and TUNEL signals increased with the time. At 4 day, most of 
the cleaved caspase-3-positive cells (red) were found to colocalise with TUNEL positive 
(green) signals (Fig. 20). -
3.7.2 RTA experiment 
Retinas treated with 0.01 nmol of RTA were examined at 1, 2 and 3 day post-injection. 
Overlapped cleaved casapse-3-positive (red) and TUNEL positives (green) cells were 
also detected (Fig. 21). 
3.8 EM observation 
3.8.1 TCS experiment 
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Eyes injected with 0.92 nmol of TCS at 4 day were processed for transmission electron 
microscopy. In the saline-injected control retinas, cells in the ONL were intact and the 
nuclei were of medium electron density (Fig. 22). The mitochondria and photoreceptors 
of rods and cones appeared normal. In contrast, in the TCS-treated sections, different 
stages of nuclei degenerating could be observed in the ONL of retina (Fig. 23). These 
included condensation and fragmentation of nuclear materials. Many condensed nuclei 
were observed in the ONL. Some showed condensed chromatin on the inner surface of 
the nuclear envelope. Scattered apoptotic bodies, the detached part of cytoplasm 
sometimes containing condensed chromatin, were observed. Many mitochondria had 
swollen and some had disintegrated membrane. The fact that mitochondria appeared 
more abnormal than-the other cytoplasmic organelles suggested that they were involved 
in the process of cell death. 
3.8.2 RTA experiment 
Two days after injection of 0.01 nmol RTA, the retinal sections were processed and 
observed under EM (Fig. 24). Many grouped cells and their organelles were obviously 
swollen and enlarged. Disintegrated cell membranes were observed and many cells 
extruded their cellular components into the extracellular space. The observation 
significantly differed from that in the TCS experiment. 一 
3.9 Summary of results: mode of cell death 
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I 一 T ^ RTA RCA 
Main cell Apoptosis Necrosis Necrosis 
death type 
TUNEL 4days 2-3days 2-3days 
peak 
Cleaved Overlapped with Overlapped with y / ^ 
caspase-3 TUNEL +ve cells TUNEL +ve cells 
EM Condensed nuclei Grouped lysed cells / 
Swollen mitochondria Swollen organelles / 
Apoptotic bodies Extruded cell / 
components / 
3.10 Localisation of type I RIPs 
To locate the RIPs after injection into the eye, the RIPs were labeled with fluorescein 
isothiocyanate (FITC) by conjugation. FITC-TCS and FITC-RTA were thus prepared. 
Pure FITC was used in the control rats. 
Pure FITC control 
Eyes were injected with 3 nmol of pure FITC. This dose was 6 folds of that of FITC-
TCS, because the molecular ratio of FITC to TCS was 6 in the conjugated FITC-TCS. 
Then the retinas were fixed and processed at 1 to 4 day for confocal microscope. Green 
FITC signals were found diffusely distributed in the nerve fiber layer (NFL), the inner 
plexiform layer (IPL) and the outer plexiform layer (OPL) (See Fig. 25). Signals were 
absent from nuclei of cells of the ganglion cell layer (GCL) and outer nuclear layer 
(ONL), but were present in nuclei in the inner nuclear layer (INL). There were also some 
signals from radial strands in the outer nuclear layer and an even staining in the outer 
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limiting membrane (OLM). The staining pattern remained similar until 4 day post-
injection. 
3.10.1 FITC-TCS 
FITC conjugated TCS injection 
Eyes were injected with 0.52 nmol of FITC-TCS, and were fixed and processed at 1 to 4 
day for confocal microscope. Green FITC signals were found distributed over the whole 
retinal section. The fluorescence pattern was different from that of pure FITC. In the 
pure-FITC sections, the fluorescent areas appeared homogeneous, whereas in the FITC-
TCS sections, fluorescent areas appeared granular. This might be due to the conjugation 
of six FITC molecules to one TCS molecule (since the molecular ratio was 6，see 3.11)， 
suggesting that the green signals might represent the location of the conjugated TCS. 
(See Fig. 26.) 
At 1 day, the signals scattered over the retina: in the nerve fiber layer (NFL), ganglion 
cell layer (GCL), inner plexiform layer (IPL), inner nuclear layer (INL), out plexiform 
layer (OPL) and outer nuclear layer (ONL). The signals stopped abruptly at the out 
limiting membrane (OLM), forming a fluorescent green line there (Figs. 26a, b and c). 
At 2 day, the signals had crossed the OLM and appeared in the pigmented epithelium 
(Figs. 26d, e and f). The green line at the OLM became wider and the signals in the 
adjacent ONL had increased. At 3 day, signals outside the OLM had further increased, 
whereas signals inside the OLM, namely the NFL, GCL, IPL, INL and ONL, were 
reduced (Figs. 27a, b and c). At 4 days, signals in whole retina became reduced, both in 
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the retinal cell layers and in the pigment epithelial cells (Figs. 27d, e and f), possibly 
because of the degradation of the conjugate. 
3.10.2 FITC-TCS and Miiller cell double staining 
Eyes were injected with pure FITC or 0.52 nmol FITC-TCS, and were processed with an 
immunohistochemical method for glutamine synthetase (GS). This method allowed 
visualisation of Miiller cells, and at the same time FITC or FITC-TCS as well. 
Control eyes injected with pure FITC. The GS signal pattern was similar to the pure 
FITC patterns at 1 to 4 day (Fig. 28，cf Fig. 25). GS was strong in the inner plexiform 
layer (IPL) of the retina, where the processes of the Miiller cells located (Fig. 28). 
Signals of the outer limiting membrane (OLM), which was formed by Miiller cells, 
formed a distinct line. GS signals appeared to be located in bodies of Miiller cells, and 
were present mainly in the middle of the INL. FITC appeared to be selectively taken up 
by the nuclei located also in the inner segment of INL. However, the GS-positive cell 
bodies did not overlap with the FITC-concentrated nuclei. Hence the FITC concentrated 
cells did not appeared to be GS-positive Miiller but were more likely to be amacrine 
cells and/or bipolar cells. 
Eyes injected with FITC-TCS. The signal patterns of FITC-TCS were similar to those 
observed in the FITC-TCS sections not reacted for GS activity (see 3.8.1). The signals 
were diffusely distributed at the beginning, gradually moved towards the outer layers, 
and then declined in all layers. These patterns were different from those obtained with 
pure FITC labeling (Fig. 29). 
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At 1 day after FITC-TCS injection, the GS signals showed a similar pattern as the GS 
signals of pure FITC-injected control (Fig. 29, c, f and Fig. 28). The outmost green line 
of FITC-TCS fluorescence coincided completely with the OLM, which was formed by 
Miiller cells. The GS signals became weaker and weaker with time (Fig. 30). 
3.10.3 Miiller cell and TUNEL double staining 
Eyes were injected with 0.92 nmol of TCS, and were fixed at 1 to 4 day for processing 
with both GS and TUNEL methods. These combined methods were likely to detect 
Miiller cells and cells that were like be undergoing apoptosis. The results showed that 
red signals (likely Miiller cells) and green signals (likely apoptotic cells) were co-
localised. This suggested that Miiller cells were undergoing apoptosis (Fig. 31). 
3.10.4 FITC-RTA 
In this experiment, the concentration of the conjugate was much lower than that in the 
above experiment (in 3.8.1) because of the toxicity of RTA, and the molecular ratio of 
the conjugated RTA was lower than that of FITC-TCS. Therefore the dose of FITC was 
reduced to 0.04 nmol for the control; this dose was too low to trace. One to three days 
after pure FITC injection, nothing was detected in the retina under the confocaf 
microscope (Figs. 32 a, b and c). 
One to 3 days after administration of FITC-RTA, green signals were detected only in 
some regions of retina. Most areas of retinas were dark (Figs. 32 and 33). But one day 
after FITC-RTA injection, numerous infiltrate cells were observed in the retina, 
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especially in the layers nearby the vitreous chamber. At 2 day, more infiltrate cells were 
present. At 3 day, damaged retinal structure was obvious; toxin molecules were 
distributed along a wavy line, which was very likely to be a blood vessel (Figs. 33 d, e 
and f). 
3.10.5 Summary of results: route of intoxication 
Pigment epithelium 
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Pure F ITCspec i f i c to INL nuclei 
3.11 Glial cell reactions after RIP treatment 
Eyes were injected with 0.92 nmol TCS, 0.01 nmol RTA or 0.01 nmol RCA and glial 
cells were studied at different times afterwards. Muller cells were demonstrated by the 
glutamine synthetase (GS) method, astrocytes by glial fibrillary acidic protein (GFAP) 
method, and microglia by the fluorescein labeled lectin from Griffonia simplicifonia GS-
I isolectin B4 (FITC-GS-I-B4) method. 
3.11.1 TCS experiment 
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Overall GS activity, normally used to detect Muller cells, was reduced throughout the 
retina at 4 day post-injection, especially in the inner plexiform layer (IPL) (Fig. 34). The 
activity in the inner nuclear layer (INL) was also reduced at 7 day and remained low 
when observed at 1 mouth. 
Glial fibrillary acidic protein (GFAP), normally used to detect astrocytes, was stronger 
at 1 and 4 day after TCS injection than that in control sections (Fig. 35). At 7 day, the 
activity had decreased, and it remained low when observed at 1-month. The activity was 
located mainly the nerve fiber layer (NFL), and not much noticeable in the INL, where 
the Muller cell bodies were located, or in the ONL, where the processes of the Muller 
cells were. 
FITC-GS-I-B4 signals were slightly increased at 4 day (Fig. 36). The elongated 
structures, often hollow, suggested that the signals were located in blood vessels. 
3.11.2 RTA experiment 
From 1 day on, GS for Muller cells was found noticeably reduced in the nerve fiber 
layer (NFL), inner plexiform layer (IPL), inner nuclear layer (INL) and outer nuclear 
layer (ONL) (Fig. 37). 
GFAP signals were stronger than control since 1 day (Fig. 38，cf Fig. 35). Strong signals 
were also observed along blood vessels. With time, the signals intensified to different 
extents at different areas. The increased staining was observed in IPL and INL, as well 
as in ONL (Fig. 38). The increase was probably located in the Muller cells. When the 
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retina is injured, GFAP staining has been reported to be present in the Miiller cells, 
though the mechanism is not known. 
FITC-GS-I-B4 was greatly increased at 3 day (Fig. 36). The signals were located at blood 
vessels and round cells. Counterstaining with PI demonstrated nuclei at the centre of the 
FITC-GS-I-B4-positive cells, which were presumably stimulated microglia or infiltrating 
macrophages. 
3.11.3 RCA experiment 
GS activity began to decrease at 1 day. The decrease was most obvious in the IPL (Fig. 
40). The decrease continued with time in all retinal layers. At 7 day, only a little activity 
was detected (Fig. 40d). 
GFAP staining was increased at 1 day in the nerve fiber layer (NFL) (Fig. 41 c, f and Fig. 
35). The increase continued with time in the INL and ONL (Fig. 41). The positive radial 
strands in the ONL suggested that GFAP was present in the process of the Miiller cells. 
The change was similar with that in the RTA experiment (Fig. 38). 
FITC-GS-I-B4-positive cells were greatly increased (Fig. 42). The change resembled that 
in the RTA-treated retinas (Fig. 39). 
3.11.4 Summary of results: glial reactions 
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GS 丄si -l-l 丄丄 
(Muller) 
GFAP Slightly TT TT 
(Astrocyte) T 
GS-I-B4 Slightly TT TT 
(Microglia) T 
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CHAPTER 4. Discussion 
4.1 General effects of RIPs on rat retinas 
4.1.1 Effects of trichosanthin (TCS) 
Ribosome inactivating proteins (RIPs), such as ricin, have long been used in 
neuroanatomy and neuroscience researches. They are very efficient tools to produce 
neural lesion for pathway tracing and other experimentations. The B chain of type II 
RIPs bind nearly all cell surfaces, allowing the entry of the toxic A chain into the cell. 
The toxic A chain is where the ribosome-inactivating activity lies, for it enzymatically 
-destroys ribosome RNA, hence inhibiting protein synthesis and eventually killing the 
cell. Ricin, a typical, commonly used type II RIP, can kill most types of neurons. There 
is exception. Injection of ricin into the striatum did not kill neurons that project to the 
striatum (Wiley & Lappi 1994). This may be due to some special properties of the glial 
environment, or to the membrane properties of the projecting axons. The latter 
properties may impart some specificity between the neuronal membrane and the B chain, 
or between the neuronal membrane and the A chain, or both. There have been reports 
that TCS, a type I RIP with only an A chain, does express different toxicity to different 
cell types; that is, it is selective for cell types to produce its lethal ribosome-inactivating 
effect. However, little is known about the effect of TCS or other type I RIPs on neurons 
(Ovadia et al 1988; Wang 1990; Wiley & Lappi 1994). TCS is a well-established 
traditional Chinese medicine, but its toxicity on neurons has been little studied. It is 
therefore important to evaluate its neurotoxicity on one hand, and to study its 
mechanism on the other. 
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The thickness of the retina underwent little change in the first 3 days after the TCS 
injection. One week after the treatment, the retinas became much thinner than the 
controls. No further change in thickness was observed at one month. Hence this change 
was irreversible. Change in tissue size could be due to a cell loss or atrophy. Since TCS 
is a RIP, the change was most likely to be due to cell loss. Furthermore, from the above 
time-course study, the loss of cells occurred quite abruptly, and was completed in a very 
short time. 
The present results showed that TCS did not cause prominent retinitis or retinal necrosis. 
The histology of the TCS-treated retinas was the same as the controls. The three key 
features of inflammation - hyperaemia, exudation and emigration of leucocytes (Govan 
et al 1981)，were not obvious in the TCS-treated retinas. An objective, semi-quantitative 
histopathologic scoring system was employed to grade the severity of retinitis with 
respect to vitreous chamber infiltrate, retinal cytological disruption and retinal inflamed 
architectural destruction. The scores for the TCS-injected retinas were very low at any 
time-point after the treatment, at both the peripheral and central retinas; they were 
statistically similar to the controls. Hyperaemia and exudation cause tissue swelling. The 
absence of tissue swelling in the TCS-treated retinas further proved that TCS did not 
induce inflammation in the retina. 
We also investigated cell loss in the ganglion cell layer (GCL), the inner nuclear layer 
(INL) and the outer nuclear layer (ONL). The loss in the ONL caused by TCS was very 
pronounced. At the highest dosage used (1.84 nmol), there were hardly any ONL cells 
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left in the retinas. Cell loss was also observed in the INL, but at a lower rate than that in 
the ONL. In contrast, TCS did not appear to destroy the GCL cells even at the highest 
dosage. These results suggested that TCS had selective toxicity to retinal cells. It was 
most toxic to the ONL cells. The ONL was the layer farthest away from the vitreous 
chamber. Therefore, the specific toxicity of TCS on ONL cells was probably not due to 
the diffusion gradient. 
4.1.2 Effects of ricin A chain (RTA) 
Ricin A chain (RTA) was isolated from the intact molecule of type II RIP ricin, and 
possesses a structure similar to many type I RIPs, such as trichosanthin (Kubota et al 
1987; Maraganore et al 1987; Collins et al 1990; Zhou et al 1994). RTA was extensively -
used in synthesis of hybrid toxins by conjugating with molecules that bind to specific 
cell types, namely monoclonal antibodies and hormones (Simmons et al 1986; Candiani 
et al 2001). RTA alone is generally believed to be inactive unless translocated into the 
cytoplasm following binding to the cell surface either by ricin B chain (RTB) or by the 
conjugated antibody or hormone. The RTA molecule possesses a mannose 
oligosaccharide chain (GlcNAc^Maiu). There have been a few reports that RTA alone 
could enter and kill certain cells, such as macrophages and Kupffer cells, by binding of 
its mannose sugar to the mannose receptors on the surface of these cells (Simmons et al 
1986，Zenilman 1988). Additionally, recombinant ricin containing galactose-deficient B 
chain was toxic to cells bearing mannose receptors, suggesting that the galactose binding 
property of intact ricin was not required for ricin toxicity (Frankel et al 1997). In these 
cells, the role of the galactose-binding RTB is therefore insignificant. Some papers even 
reported the protective function of RTA without causing acute metabolism of 
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immunotoxin, which was opposite to the toxicity of RTA (Crosson et al 1992; Handa et 
al 1996; Griffiths et al 1999). The studies on type I RIP toxicity were focused on 
immune or immunological modified cells, using mostly modified RIPs. How common 
the mannose-receptor mediated toxicity is amongst normal cells is unknown. 
Furthermore, the question remains whether RTB continues to play a role in the 
intracellular process of intoxication once the toxin molecule has been internalised. 
The present results showed that RTA was toxic to normal retinal cells. However, the 
pattern of retina damaged by RTA was very different from that by TCS. The dosage of 
RTA used to produce observable changes was about one hundredth of TCS. Whereas 
TCS at the dosage as high as 1.84 nmol did not cause obvious inflammatory damage, 
RTA at the dosage of 0.07 nmol caused extensive retinal necrosis and inflammation one 
week after the treatment; even at the dosage as low as 0.01 nmol, RTA stilled caused 
noticeable retinitis damage. 
After the RTA injection, the retinal thickness was significantly increased, which 
represented the swelling of the retinal tissues. Subsequently, at one week after the 
injection, the retinas became thinner, which suggested the degeneration and/or atrophy 
of retinas. Compared with the TCS treatment, the RTA treatment caused more severe 
swelling, but about the same extent of reduction in thickness. These results suggested 
that RTA caused more severe inflammation than TCS, but about the same extent of 
degeneration and/or atrophy as TCS. 
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The semi-quantitative histopathologic scores for the RTA-treated retinas were 
significantly higher than those of the controls and TCS-treated retinas. The retinitis 
caused by RTA peaked around at 3 day and the retinal cell loss appeared about 7 days 
after the injection. This observation matched well with the change in thickness. It also 
matched well with a previous finding that after injection of a ricin immunotoxin into the 
superior rectus muscle, the inflammation peaked at 3 day and the muscle loss appeared 
at 7 day after the injection (Christiansen et al 2000). 
Put together, all these results showed that RTA caused significant retinal inflammation. 
Since the histopathologic scoring system included features of necrosis (vacuolation and 
cellular infiltration), necrosis was also indicated. Inflammation with necrosis was 
observed at high or low dosages of RTA. Results of the time-course study suggested 
that the necrosis may be resulted from infiltration of numerous inflammatory cells, since 
this event was observed at 1 day before necrotic changes, which occurred at 3 day. 
4.1.3 Effects of ricinus communis agglutinin (RCA) 
The pattern of retinal damage by this type II RIP was very similar to that by the type I 
RIP, RTA. The effects were comparable for RCA and RTA at same dosages, but very 
different from that produced by TCS. RCA caused widespread and necrotic cell death 
and completely disrupted the retinal structure one week after the injection of the higher 
dose (0.08 nmol). 
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RCA initially caused swelling of the retina. Subsequently, at one week after the injection, 
the retinal thickness decreased. The change in retinal thickness was very similar to that 
of the RTA groups, but significantly different from that of the TCS groups. 
The data on retinitis showed parallel results between RCA and RTA groups. The scores 
for the three histopathological parameters did not differ significantly from those of the 
RTA-treated retinas, but differed significantly from those of the controls or TCS-treated 
retinas. 
4.2 The mechanisms of cell death 
Cell death is normally classified as either necrosis or apoptosis (Kuan & Passaro 1998; 
Best et al 1999; Phaneuf & Leeuwenburgh 2001). In necrosis, there is swelling of the 
cell and organelles, membrane breakdown, significant inflammatory response and 
invasion of macrophages; cells undergo lysis in groups and the degenerative process 
may spilled over to surrounding cells and extracellular spaces. In sharp contrast, 
apoptosis is an active, energy dependent and highly regulated process for deletion of 
single cells. At the early stage of apoptosis, the cell membrane begins blebbing but 
remains intact. Membrane integrity can be detected by combined Annexin V -
propidium iodide method for culture experiments but not for sections, because cells in 
sections have been fixed and therefore are not alive to reject the dye. At the mid stage of 
apoptosis, many proteins are cleaved and activated. Among these proteins is the 
activated caspase-3. It is the best known, key common effector for DNA fragmentation 
and is therefore used in this study. At the late stage, chromatin is compacted into 
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uniformly dense masses and breaks into fragments; the cell shrinks, and forms fragments 
containing condensed chromatin, organelles and cytoplasm. These membrane-bound 
fragments are known as apoptotic bodies. The possible existence of both DNA 
fragmentation and apoptotic bodes were examined in this study using TUNEL method. 
The best evidence of apoptosis is perhaps direct visualisation under the electron 
microscope. 
4.2.1 Cell death caused by TCS 
TCS-treated retinas were processed with TUNEL method, which detects fragments of 
DNA. One day after TCS treatment, TUNEL positive signals were observed in the inner 
retinal layers. The positive signals peaked at the fourth day and were mostly prominent 
in the ONL; then they became much weakened at 7 day, and completely disappeared at 
one month. This suggested that TCS rapidly killed retinal cells, first in the inner layers 
and subsequently in the ONL. To further investigate the morphology of TUNEL positive 
cells, the DAB stained TUNEL sections were observed with an oil-immersion objective. 
An apoptotic cell would contain a condensed nucleus or fragments of DNA along the 
nuclear envelope, while necrotic cell contains DNA released to the cytoplasm (Tang et 
al 1997). Both types of cell death were found in the TCS-treated retinas, but apoptotic 
cells were obviously in predominance, regardless of the dosage. Even at the lowest 
dosage of TCS used, a few TUNEL positive cells were still detected. The dosage 
decided the severity, but not the type of cell death. 
TCS-treated sections showed positive signals of cleaved caspase-3 activity. Many of 
them were co-localized in the same cells as the TUNEL signals. Since the activation of 
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caspases is at the mid stage of apoptosis and TUNEL detected DNA fragmentation 
happens at the late stage of the process, this may explain why some of the positive 
signals did not overlap. This further proved that apoptotic cell death did occur after TCS 
treatment, and the activation of caspase-3 was involved in the cell death process. The 
result was consistent with previous results on the apoptosis of retinal neurons or other 
neuronal cells, in which the activation of caspase-3 was also observed (Wolozin & Behl 
2000; Barber et al 2001 ； Chen et al 2001 ； Meyer et al 2001; Singh et al 2001). 
Under the transmission electron microscope, many nuclei at different stages of 
degeneration were observed in the ONL of TCS-treated retinas at 4 day after injection, 
when TUNEL signals peaked as shown above. Some of "the nuclei appeared very 
electron-dense, suggesting condensation of chromatin, and some showed condensation 
in the inner surface of the nuclear envelope. Apoptotic bodies with intact cell 
membranes were also observed. Many enlarged swollen mitochondria were observed. 
Since mitochondria may enlarge if not well preserved, the control retinas were also 
investigated under the EM. The normal morphology of cells and mitochondria in the ‘ 
control sections excluded the possibility of poor preservation. The EM observation 
confirmed that the cell death induced by TCS was mainly apoptosis. One the other hand, 
the swollen mitochondria suggested that the pathway of the apoptosis of the 
photoreceptors induced by TCS involved the mitochondria. This agrees with the 
previous reports on apoptotic pathways in photoreceptors (Liu et al 1999; He et al 2000; 
Chen et al 2001, Singh et al 2001). The degeneration of mitochondria resulted in escape 
of cytochrome c into the cytosol, which was capable of activating endonucleases or pro-
caspases, such as pro-caspase-3 upon opening of the mitochondrial permeability 
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transition (PT) pore. The PT pore was a multi protein complex formed at the contact site 
between the mitochondrial inner and outer membranes functioning as a Ca(2+)-， 
voltage-, pH- and redox-gated channel with several levels of conductance and possible 
ion selectivity (Kroemer 1999). Afterwards, the process of apoptosis was triggered. The 
above pathway was very likely to be that of the apoptosis of photoreceptors caused by 
TCS. 
The present results showed little sign of necrosis after TCS treatment. Early studies on 
TCS toxicity on placental tissues reported necrosis, but not apoptosis (Anonymous, 
1976; Wang, 1985; Xi et al 1997). Recently, some papers reported that it has DNase 
and RNase activities (Kerr et al 1994; Ru et al 2000; Zhang et al 2001). The present 
results on retinal thickness, TUNEL and caspase-3 signals, and ultrastructural study, all -
showed that TCS induced apoptosis, which peaked at about 4 day post-injection, and 
that the cell lost was most pronounced in ONL. Hence there are contradictions amongst 
the present and previous studies. It might be possible that different cell types react 
differently to a RIP. Alternatively, it may be possible that in the early studies, TCS 
acted through the circulation. The extensive necrosis seen in those studies might be 
secondary to the toxic effect on blood cells or vessels; that is, it might be due to 
ischemia (which is a powerful effecter for necrosis). It might also be necessary to use 
recombinant TCS to repeat the early experiments, so that any possibility of 
contamination by minute trace of lectins could be eliminated. 
4.2.2 Caspase-3 and the retina of RCS rat 
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Retinas of the Royal College of Surgeons (RCS) rats are known to undergo apoptotic 
degeneration. The degeneration occurs amongst photoreceptors and peaked at the age of 
four to five weeks (Tso et al 1994). Therefore, RCS retinas are often used as a positive 
control for apoptosis. The apoptotic related proteins, such as caspase-1 and caspase-2, 
have been reported to be involved in the apoptotic pathway in the retinas of RCS rats, 
but the immunohistochemical signals were very few and weak (Katai et al 1999). Bci-2 
expression has been reported not altered in the apoptosis of RCS retinas (Sharma 2001). 
So far, no finding has been reported about caspase-3 in the eyes of RCS rats. 
In our experiment, immunohistochemical reaction of cleaved caspase-3 was carried out 
on cryostatic sections of the RCS retinas. The activated caspase-3 signals only existed 
in the photoreceptor layer (ONL) of RCS retinas. TUNEL signals were also located 
only in ONL. Furthermore, many of caspase-3 positive signals overlapped with the 
TUNEL signals. This result showed that caspase-3 might be involved in the retinal 
degeneration of photoreceptors of RCS rats. 
This is probably the first time that the activation of caspase-3 was observed to play a 
role in the apoptosis of the RCS retinas. This observation may be useful for discovering 
the apoptotic pathway of RCS retinas and for treating the retinal degeneration in RCS 
rats. For the latter purpose, anti-casapse-3 substances may be used to maintain the RCS 
photoreceptors. 
4.2.3 Cell death caused by RTA 
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One day after RTA treatment, many TUNEL positive cells were observed and the 
signals were stronger than those of the TCS-treated retinas. The positive signals peaked 
at two to three day, and decreased at one week after RTA injection. In addition, the level 
of retinitis was significantly higher than that in the TCS sections. 
The RTA-treated retinas showed also caspase-3 signals, some of which were colocalized 
with the TUNEL signals. This showed that activated caspase-3 might be involved in the 
pathway of RTA-induced retinal apoptosis. 
Under the electron microscope, many enlarged and swollen cells with swollen organelles 
were observed in groups. Many cells with broken cell membranes extruded their cellular 
components into extracellular spaces. This suggested necrotic cell death caused by RTA. 
In contrast, few condensed nuclei or apoptotic bodies were present in the sections. The 
EM investigation confirmed that RTA mainly resulted in necrosis. 
The results clearly showed that RTA-induced cell death proceeded mainly in the 
necrotic mode and to some extent in the apoptotic mode. Some papers reported that RIPs 
induced apoptosis at a high dose and necrosis at a low dose (Dypbukt et al 1994; 
Bonfoco et al 1995). But our results showed that in the rat retina, TCS caused apoptosis 
- at both low and high dosages without obvious signs of necrosis, whereas RTA resulted 
in marked necrosis accompanied by apoptosis at any dosage. Although the amino acid 
sequences of both TCS and RTA are very similar (Kubota et al 1987; Maraganore et al 
1987; Zhou et al 1994), they have different 3D structure. Furthermore, trichosanthin is a 
simple protein without any sugar group, whereas RTA is a glycoprotein containing a 
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mannose sugar (Simmons et al, 1986; Zenilman et al 1988; Fankel et al, 1997). It may 
therefore be possible that the sugar-receptor binding may induce necrotic changes, 
whereas the RIP action itself may induce apoptotic changes. Within the RTA-treated 
retina, it may be possible that cells having mannose receptors on their surface may 
proceed to necrosis on RTA intoxication, whereas cells not having mannose receptors 
may proceed to apoptosis. It may be further speculated the necrotic events starts at the 
cell membrane, whereas the apoptotic events starts in organelles or cytosol. As discussed 
below, necrosis could also be resulted indirectly by the action of RTA on blood vessels. 
4.2.4 Cell death caused by RCA 
RCA caused marked necrosis and retinitis at all experimental doses, but apoptosis also 
occurred. The RCA induced TUNEL reaction for DNA fragmentation followed the same 
spatial and time pattern as those observed after RTA treatment. 
• The mechanism of apoptosis caused by type II RIPs, such as ricin, is not clear (Ling et al 
1994). It has been reported that the apoptosis caused by ricin involved various caspases 
including caspase-3, caspase-like proteases, the Bcl-2 family proteins, Ca^'^-dependent 
proteases, protein kinase and polymerase cleavage activity (Komatsu et al 1998; Hu et al 
2001). The cleavage of nuclear DNA by ricin may be due to the direct action of the RIP 
itself rathcF than to ribosome inactivation (Brigotti et al 2002). 
RCA and RTA are different RIPs, the former possessing a lectin (cell-binding) chain 
whereas the latter not. However, their toxicity to the rat retina was extremely similar. 
This support the proposals of this study that (i) the A chain moiety alone, so far that it 
- 8 0 -
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- 8 0 -
has a mannose sugar (as in the case of RTA), is capable of binding to mannose receptor-
bearing retinal cells; (ii) the binding causes necrosis; (iii) the A chain moiety, whether it 
has a sugar (as in RTA) or not (as in TCS), is capable of causing ribosome-inactivation 
and apoptotic changes. The proposal in (i) implicates that the galactose receptor-bearing 
RTB is not involved in the intoxication of cells lacking galactose but possessing 
mannose receptors. This proposal agrees with the report that RTB may not be required 
for the entry of ricin into mannose receptors-bearing cells (Frankel et al 1997). The 
reason why biding of the mannose receptor could cause necrosis is further discussed 
below. 
4.2.5 Mechanism of RTA-induced necrosis 
In contrast to the effect of TCS, RTA caused acute retinitis and necrosis. These changes 
appeared to start from the inner layers of retinas. For example, the leucocyte infiltrate 
starts from the nerve fiber layer (NFL). Therefore, RTA intoxication of the retina may 
involve a mechanism not employed by TCS. 
RTA has been reported to enter cell through the selective uptake by mannose receptors 
on the cell membrane (Simmons et al 1986; Zenilman et al 1988; Fankel et al 1997). It is 
known that mannose receptors are distributed in the membrane of rat endothelial cells 
(Linehan et al 2001). It has also been reported that RTA produced a direct toxic effect on 
endothelial cells of vessels, causing leakage of blood vessels (Soler-rodriguez et al 1993; 
Baluna et al 1996; Lindstrom et al 1997). Therefore we put forward a hypothesis that 
RTA may directly enter and damage rat vascular endothelial cells via mannose receptors, 
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thereby causing leakage of leukocytes and mediators that finally result in inflammation 
and necrosis of the retina. 
4.3 The mechanisms of type I RIPs entering cells 
The entry of RIPs into cells involves binding of the toxin to cell membrane and then 
endocytosis (Sandvig & van Deurs 1999，2000). The above discussion shows that 
binding of the RIP may involve galactose-receptors on RTB and galactose on cells, or 
mannose on RTA and mannose-receptors on cells (Cavallaro 1995; Sandvig & van 
Deurs 1999, 2000). Various modes of endocytosis for ricin and other toxins have been 
proposed. For TCS, neither the binding nor endocytotic mechanism is well understood. 
How type I RIPs enter cells remains unclear, although it has once been proposed that 
type I RIPs crossed the cell membrane through passive mechanisms such as fluid-phase 
pinocytosis (Cavallaro 1995). 
4.3.1 Transport of TCS in retinal cells 
TCS has been reported to enter cells through some specific receptors in cell membranes 
other then the above mentioned ones. These receptors include low density lipoprotein 
receptor-related protein (LRP), megalin and chemokine receptors including CXCR4 
(Zhao et al 1999; Chan et al 2000). A recent study showed that the endocytotic receptor 
LRP existed in the Muller cells of the rat retina (Shock et al 1995). It is therefore 
possible that LRP-binding may be the entry mechanism of TCS into the Muller cells. 
Furthermore, LRP was also reported to be present in the rat retinal epithelial cells, and 
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CXCR4 in the human retinal pigment epithelial cells (Zheng et al 1994; Crane et al 
2000). Therefore it is possible that TCS entered the pigment epithelium of the rat retina 
by interaction with these receptors. 
The present results showed that TCS was specifically toxic to the outer nuclear layer 
(ONL) cells. The specificity could not be due to the ease of diffusion of TCS to the ONL, 
since the toxin was administrated into the vitreous chamber, and the ONL was farther 
from the toxin than most of the other layers. 
One day after FITC-TCS injection, the toxin scattered all over the retina but sharply 
stopped at the OLM. A bright line, following exactly the outer limiting membrane (OLM) 
was formed. It is known that the OLM is formed by Muller cells. This suggests that 
TCS may be taken up and transported by Muller cells, since Muller cells span nearly the 
entire thickness of the retina, from the inner limiting membrane (ILM) to the OLM, and 
contact and ensheath all types of retinal cell bodies as well as processes (Bringmann & 
Reichenbach 2001). The toxin molecules in the bodies and processes of Muller cells 
were therefore spread out through the whole retina. In the second day, the signals 
crossed the OLM and were taken up by the pigment epithelial cells. This may be 
because the Muller cells released the toxin, which was subsequently endocytosed by the 
adjacent pigment epithelial cells. In the third day, an even, non-granular signal pattern in 
the photoreceptors, especially in the outer segments, was observed. This is probably 
because FITC was cleaved from the conjugate molecules by the pigment epithelial cells 
and the freed FITC was taken up by the photoreceptors or escaped into the extracellular 
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spaces. In the fourth day, the intensity of FITC-TCS was greatly decreased, indicating 
removal or disintegration of the conjugate. 
These results agreed with the above discussion on possible TCS receptors on Miiller 
cells and pigment epithelial cells. The FITC-TCS conjugate did not appear to 
concentrate in the cell bodies or nuclei of the photoreceptors, suggesting that TCS did 
not enter these cells. 
The present results agreed with the previous reports on apoptosis in the INL and ONL of 
the retina and expression of caspase-3 in these areas (Liu et al 1999; He et al 2000; Chen 
et al 2001, Singh et al 2001). The cell death in the inner nuclear layer (INL) and outer 
nuclear layer (ONL) may be due to the intoxication of Miiller cells and the pigment 
epithelium. The morphological relationship between Miiller cells and retinal neurons 
allows a multitude of functional interactions with the neurons, including extracellular 
ionic homeostasis and glutamate recycling by Miiller cells (Bringmann & Reichenbach 
2001). The Miiller cells protect nerve cell by release of basic fibroblast growth factor, 
uptake and degradation of the excitotoxins such as glutamate, and secretion of the 
antioxidant glutathion. Abnormality of Miiller cells has been suggested to be the cause 
of various retinal degenerations. In our experiment, after TCS injection, the reactivity of 
anti-glutamine synthetase (GS) in the Miiller cells decreased with time. This may be due 
to death of Miiller cells or their loss of function. The TUNEL results showed that death 
of Miiller cells did occur. Whatever the actual fate of the Miiller cells, their intoxication 
is likely to produce an adverse effect on their trophic interaction with neurons. The loss 
of trophic signals, such as growth factors, has been suggested to be a major trigger signal 
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that causes neuronal apoptosis (Wolozin & Behl 2000). Furthermore, the lack of 
neurotrophic support has been suggested to be one of the primary regulatory steps in the 
apoptosis of developing retinal neurons such as ganglion cells (Oppenheim 1991; Levine 
1997; Nickells 1999). 
Furthermore, uptake of TCS into the pigment epithelium may also contribute to the cell 
loss in the ONL. The pigment epithelium cells have several functions including 
absorption of light, removal of heat, and provision of mechanical, metabolic and trophic 
supports to photoreceptors (Saude 1993). The TCS intoxicated pigment epithelium may 
no longer be able to support the ONL cells. 
4.3.2 The uptake of pure FITC by rat retina 
Control eyes for the FITC-TCS experiment were injected with pure FITC. Over the 4 
days of observation, the signal pattern remained unchanged. The signals showed a 
pattern of selective distribution, since it was mainly concentrated in the inner segmental 
nuclei of INL, diffusedly distributed in the outer segmental nuclei of INL, and was 
absent in the nuclei of ONL and GCL. The amacrine and bipolar cells of the inner 
segment of INL were probably labeled. To our knowledge, this was perhaps the first 
time that pure FITC was injected into rat vitreous chamber to demonstrate active uptake 
by specific retinal cell types. The results showed that FITC may be a potential dye for 
differential labeling of retinal neurons in in vivo and in vitro studies. 
4.4 Reactions of glial cells 
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4.4.1 Glial cell reactions in TCS experiment 
The only three types of glial cells in the retina are Miiller cells, astrocytes and microglia. 
Miiller cells and astrocytes were detected by immunohistochemistry and microglia were 
detected by lectin histochemistry. 
Fibers of Miiller cells make up the retinal connective tissue. They ramify through the 
entire retina, extending into spaces between the neural elements, and form the external 
and internal limiting membranes (Saude 1993). They are important in the protection and 
nutrition of retinal neurons (Bringmann & Reichenbach 2001). The decrease in Miiller 
cells prior to the loss in photoreceptor cells in the chick was considered to cause such a 
loss (Li et al 2001). This result in chick supports the hypothesis that loss of Miiller cells 
may result in cell death in the ONL (see 4.3.1). 
Astrocytes are mainly found in the ganglion cell layer (GCL) and nerve fiber layer 
(NFL). They have short and long projections extending in all directions (Saude 1993). 
Many also attach themselves to capillaries, and others lie against the outer walls of nerve 
cells. In injury, the activity and number of astrocytes increase, and GFAP expression is 
increased. In this study, GFAP expression was only slightly increased over a short 
period of time, and this might implicated that TCS did not have much effects on 
capillaries and GCL cells, where astrocytes are chiefly located. This could be explained 
by the findings that (i) the GCL cells did not decrease significantly; (ii) the capillaries 
did not increase and enlarge significantly; (iii) TCS did not induce significant 
inflammation of the retina. 
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It has been reported that GFAP can be expressed in proliferating Muller cells after 
retinal injuries (Humphrey et al 1997). In the TCS experiment, GFAP was not observed 
in Muller cells, probably because of TCS selectively caused intoxication of Miiller cells 
instead of their proliferation. 
Microglia are widely distributed in the CNS including the retina. Normally they are in 
ramified or quiescent form. When activated, they become amoeboid in shape and may 
present MHC class II molecules and act as antigen presenting cells. They may 
proliferate as phagocytotic cells when there is damage (Saude 1993). Micorglia are 
indicated by GS-I-B4 activity. In our TCS experiment, only a small increase in GS-I-B4 
activity on retinal blood vessels was detected, but positive cells were not found. This 
results suggest that microglial reaction was not strong enough to be detected by the 
lectin, or that the microglia did not proliferate substantially after the TCS treatment. 
With such a low microglial activity, the debris of dead apoptotic cells (apoptotic bodies) 
may be mainly engulfed and consumed by nearby healthy cells. 
4.4.2 Glial cell reactions in RTA and RCA experiments 
After RTA or RCA treatment, GS activity indicative of Muller cells decreased. The 
change was similar to that in the TCS experiment, but the mechanisms may be different. 
In the RTA and RCA experiments, the loss of GS activity was probably due to non-
selective necrosis of retinal cells including Muller cells. 
The GFAP and GS-I-B4 activity were both significantly stronger than those in the TCS 
experiment. However, GFAP was also expressed in the Muller cells as well following 
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the RTA or RCA treatment. It might be possible that some Miiller cells survived and 
they were stimulated to express GFAP. The round GS-I-B4 positive cells observed after 
the toxin treatments were possibly enlarged and proliferating microglia. Put together, the 
results suggest that both RTA and RCA non-selectively caused death of Miiller cells and 
the effects of both toxins on the rat retina were greater than those of TCS. 
4.5 Possible applications of RIPs on retinal studies 
RlP-treated retinas may serve as animal models for research on retinal diseases. 
4.5.1 Possible applications of TCS 
The characteristics of TCS intoxication of the rat retina are: (i) absence of significant 
retinal swelling and inflammation; (ii) selective and rapid deletion of cells in the inner 
nuclear layer (INL) and outer nuclear layer (ONL), especially the latter; (iii) apoptosis is 
the predominant mode of cell death; (iv) intoxication of pigment epithelial cells, which 
may be one of the factors causing the degeneration of photoreceptors. These 
characteristics favour the use of TCS-treated animals as a model of retinal degenerations 
(RDs)’ a family of retinal degenerative diseases (dystrophies) that lead to vision loss 
(Chader 2002). Dysfunction of photoreceptors undergoing apoptosis is a common 
characteristic of RDs. More than fifteen million people around the world are estimated 
to have vision loss due to various types of RDs. One kind of RDs is retinitis pigmentosa 
(RP)，the pathology of which resembles closely that of the TCS-damaged retinas. 
Research using the animal models would help to understand, treat and prevent these 
degeneration diseases. 
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Model of retinitis pigmentosa (RP) 
RP is a hereditary gradual deterioration of the retina. It afflicts approximately one in 
3000 persons worldwide, and represents the most prevalent cause of visual handicap 
among working populations in developed countries (Wong 1995; Farrar et al 2002). 
Apoptotic changes of retinal photoreceptors are thought to play a key role in RP 
pathology. It is therefore crucial to understand this process of RP. TCS can be used to 
produce rapidly and economically apoptotic RP retinas, and the severity of RP may be 
easily regulated through control of its dosage. 
Chemotherapy of retinoblastoma (RB) 
Without causing obvious inflammatory reaction, the rapid and specific toxicity of TCS 
on cells of ONL and INL may be useful for treating tumors of the eye, such as 
retinoblastoma (RB). Besides, the cell death caused by TCS was predominantly 
apoptosis, which is important in the chemotherapy of tumors. 
Retinoblastoma (RB) arises mainly from the ONL and INL (Anonymous 1977). It is a 
rare but malignant disease (Ferris & Chew 1996; Lueder et al 2001; Ross et al 2001). 
For children, RB is the most common intraocular tumor and second only to uveal 
melanoma as the most ordinary primary intraocular malignant neoplasm (Scott et al 
1999). The most common treatment is ennucleation of the eyeballs. Cryotherapy, lasers, 
and chemotherapy have also been tried for treating RB (Ferris & Chew 1996; Sabet et al 
1999; Scott et al 1999). From the present results, TCS appears to be a promising agent 
for the chemotherapy of RB. 
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Acute retinal necrosis (ARN), a reitnitis first described in Japan in 1971, occurs mainly 
in immunocompetent patients (Comer et al 2002). ARN is characterized by retinal and 
vitreous inflammation, vasculitis and haemorrhaging, and areas of retinal necrosis 
(Atherton 2001). It usually results in greatly reduced vision or blindness in the affected 
eyes. The cause is viral infection. It has been reported that TCS possesses anti-viral 
activity, presumably because of its DNase activity (Zhang et al 2001; Chan et al 2000). 
It may therefore be possible that TCS treatment be used against this disease. 
4.5.2 Possible uses of RTA and RCA 
Model of acute retinal necrosis (ARN) 
In our experiments, ricin A chain (RTA) and ricinus communis agglutinin (RCA) 
induced acute retinitis, including vitreous infiltrate, retinal vasculitis, retinal 
inflammation and necrotic damage, which are very like the pathology of ARN. 
Therefore RTA and RCA may be used to produce an animal model of ARN, which will 
help to provide insight into the pathogenesis of this disease. 
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CHAPTER 5 CONCLUSIONS 
Trichosanthin (TCS), a type I ribosome-inactivating protein (RIP), can rapidly and 
selectively cause specific cell death in the outer nuclear layer (ONL) of retina, without 
prominent inflammation and tissue swelling. TCS is also toxic to the inner nuclear layer 
(INL) cells, but has not much effect on cells in the ganglion cell layer (GCL). The type 
of cell death caused by TCS is mainly apoptosis. Degeneration of mitochondria and 
activation of caspase-3 are involved in the apoptotic pathways of the photoreceptors 
caused by TCS. TCS appears to selectively enter and destroy Muller and pigment 
epithelia cells through the receptors LRP and chemokine (CXCR4) on their cell 
membranes. Afterwards, the photoreceptors, deprived of nutrition and protection from 
the glial cells, undergo apoptotic cell death. 
The other type I RIPs, ricin A chain (RTA), is in sharp contrast to TCS in the 
» 
mechanism of toxicity. Unlike TCS, it causes marked retinal inflammation and necrosis. 
Apoptosis also occurs and the pathway includes cleavage of caspase-3. It is possible that 
RTA can enter vascular endothelial cells through mannose receptors in the cell 
membrane. Its ribosome-inactivating action causes death of the endothelial cells. 
Leakage of retinal capillaries finally results in retinitis and necrosis. RCA, a type II RIP, 
has a similar effect as RTA. 
On comparing the effects of the three RIPs, it may be suggested that the molecular 
structure of RIPs has a profound effect on the mechanism of their toxicity. The presence 
- 9 1 -
of a sugar group on the A chain is especially important. For some target cells of RIP 
intoxication, the B chain is not an obligatory requirement for the entry of the RIP into 
the cell, and its presence may not enhance the toxicity. 
Incidentally, the results showed for the first time that: (i) Activation of caspase-3 is 
involved in the apoptotic pathway in the retinal degeneration of the RCS rats. This 
finding may be useful to the study of naturally occurring cell death, (ii) Pure FITC is 
selectively taken up by nuclei of the inner segment of INL; it may therefore be used as a 
specific marker in experiments on the retina. 
Using the RIPs, we may create animal models to studying acute retinal 
inflammation/necrosis and retinis pigmentosa. The selective action of TCS may allow 
partial denervation of the retina. Its ability to selectively destroy the ONL and INL may 
be utilised in chemotherapy of retinoblastoma, which originates mainly from these two 
layers. . 
- 9 2 -
FIGURES�TABLES�GRAPHS AND LEGENDS 
Explanatory notes: 
Figures: All retinal sections were cut sagittally through the optic nerve. The 
ganglion cell layer (GCL) of retina was arranged toward the bottom of 
the figures unless indicated. 
Graphs: All graph data were mean 土 SEM (standard error). Change in retinal 
thickness was calculated as: (experimental thickness - control thickness) 
+ control thickness x 100%. Control thickness is the thickness of the 
retina of the contralateral control eye. 
Tables: Asterisk (*) indicates statistically significant difference (p<0.05) obtained 
by Student's t-test. , 
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Fig. 1 Dose-response study on TCS. Peripheral retinas one month after injection 
of TCS. a. Saline control; b, c and d, 0.46, 0.92 and 1.84 of nmol TCS 
respectively. (H&E at 400 magnification; scale bar: 50 )im). 
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Fig. 2 Dose-response study on TCS. Central retinas one month after injection of 
TCS. a, Saline injected control; b, c and d, 0.46, 0.92 and 1.84 nmol TCS 
respectively (H&E at 400 magnification; scale bar: 50 fim). 
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Fig. 3 Retinas one day after injection of 0.92 nmol of TCS, showing change in 
thickness. Both peripheral (b) and central (d) retinas were slightly 
swollen compared with the control peripheral (a) and central (c) retinas. 
(H&E at 400 magnification; scale bar: 50 )im) 
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Fig. 4 Retinas three days after injection of 0.92 nmol of TCS, showing change 
in thickness. Both peripheral (b) and central (d) retinas were similar to the 
control peripheral (a) and central (c) retinas in retinal thickness. (H&E at 
400 magnification; scale bar: 50 _ 
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Fig. 5 Retinas one week after injection of 0.92 nmol TCS, showing change in 
thickness. In both peripheral (b) and central (d) retinas, thickness was 
greatly decreased as compared to the control peripheral (a) and central (c) 
retinal thickness. (H&E at 400 magnification; scale bar: 50 |Lim) 
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Fig. 6 Retinas one week after injection of RTA. a. O.OTnmol RTA, showing 
retinal necrosis with complete destruction, presence of many infiltrating 
mononuclear cells, b, 0.04 nmol RTA. c, 0.02 nmol RTA, showing more 
intact structure than at the higher doses. The nerve fiber layer was 
ruptured, and a possible retinal cytology (indicated by *) was observed, d, 
0.01 nmol RTA, showing an enlarged capillary and retinal infiltrate cells. 
(H&E at 400 magnification; scale bar: 50 |am). 
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Fig. 7 Retinas one and three days after injection of 0.01 nmol of RTA. a. One 
day post-injection, leucocytes started to infiltrate the retina at the nerve 
fiber layer, b, Three days post-injection, marked retinal inflammation 
with cell degeneration. (H&E at 400 magnification; scale bar: 50 |Lim). 
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Fig. 8 Retinas one week after injection of RCA. a, 0.08 nmol RCA, showing 
retinal necrosis with total loss of retinal architecture and inflammatory 
cell infiltration, b, 0.04 nmol RCA. c, 0.02 RCA. d，0.01 nmol RCA, 
showing visible retinal inflammation and retinal cell degeneration. 
Integrity of retina decreased with the dosage. (H&E at 400 magnification; 
scale bar: 50 |J.m). 
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Fig. 9 Retinas one and three days after injection of 0.01 nmol of RCA. a. One 
day post-injection, showing marked retinal inflammation with preserved 
retinal structure was investigated, b, Three days post-injection, marked 
retinal inflammation with some loss of retinal structure and possible 
retinal cytology (presented by *) were observed. (H&E at 400 
magnification; scale bar: 50 |im). 
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Fig. 10 Retinas one day (a, b and c) and three days (d, e and f) after injection of 
0.92 nmol of TCS, reacted with TUNEL method, a and d, PI 
contrastaining. b, One day post-injection, a few TUNEL positive cells 
were detected and were mainly located in INL. e, Three days post-
injection, TUNEL positive cells were maximal in number and were 
chiefly located in ONL. c and f, Merged images to localize the sites of 
TUNEL positive cells. (Confocal at 400 magnification; scale bar: 50 _ 




Fig. 11 Retinas one week (a, b and c) and one month (d, e and f) after injection of 
0.92 nmol of TCS, reacted with TUNEL method, a and d, PI 
contrastaining. b, One week post-injection, the number of TUNEL 
positive cells was greatly decreased, e. One month post-injection, no 
TUNEL positive cell was detected, c and f. Merged images to localize the 
sites of TUNEL positive cells. (Confocal at 400 magnification; scale bar: 
50 ！im) 




Fig. 12 Retina injected with 0.92 nmol of TCS, and reacted with TUNEL method, 
showing apoptotic cells (a) and necrotic cell (b) in ONL of retina 
(indicated by arrows). The reaction product was developed by DAB 
method. (1000 magnification; scale bar: 20|im) 











































Fig. 13 Retinas four days (a, b and c) and 7 days (d, e and f) after injection of 
0.01 nmol of TCS. Sections reacted with TUNEL method, a and d, PI 
contrastaining. TUNEL positive cells at 4 day (b) and 7 day (e) were 
much fewer less than those after injection of 0.92 nmol TCS in Fig. 11. c 
and f, Merged images to localize the sites of TUNEL positive cells. (400 
magnification; scale bar: 50 fa.m) 




Fig. 14 Retinas one day (a, b and c) and three days (d, e and f) after injection of 
0.01 nmol of RTA. Sections reacted with TUNEL method, a and d, PI 
contrastaining. b, One day post-injection, a few TUNEL positive cells 
were detected one day after TCS treatment, e, Three day post-injection, 
TUNEL positive cells peaked, c and f, Merged images to localize the 
sites of TUNEL positive cells. (Confocal at 400 magnification; scale bar: 
50 _ 
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Fig. 15 Retinas one week after injection of 0.01 nmol of RTA. Sections reacted 
with TUNEL method, a, PI contrastaining. b, the TUNEL positive cells 
scattered over the retina, c, Merged images to localize the sites of 
TUNEL positive cells. (Confocal at 400 magnification; scale bar: 50 |J.m) 
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Fig. 16 Retinas one day (a, b and c) and three days (d, e and f) after injection of 
0.01 nmol of RCA. Sections reacted with TUNEL method, a and d, PI 
contrastaining. b and e, TUNEL positive cells one and three days after 
RCA treatment respectively, c and f, Merged images to localize the sites 
of TUNEL positive cells. (Confocal at 400 magnification; scale bar: 50 
_ 
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Fig. 17 Retinas one week after injection of 0.01 nmol of RCA. Sections reacted 
with TUNEL method, a, PI contrastaining. b, the TUNEL positive cells 
decreased than those in the 3-day sections in Fig. 16. c, Merged images to 
localize the sites of TUNEL positive cells. (Confocal at 400 
magnification; scale bar: 50 |J.m) 




Fig. 18 Retina of RCS rat reacted for both cleaved caspase-3 (a) and by TUNEL 
method (b). The two kinds of signals were localised in the ONL and some 
of them overlapped, c, merged image of a and b. d, merged image 
overlapped with a phase contrast image, e and f, enlargement of the areas 
marked in c and d . The double positive cells were indicated by arrows (a 
to d: Confocal at 400 magnification, scale bar: 50|j.m; e & f: scale bar: 
25|im). 
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Fig. 19 Retina one day after injection of 0.92 nmol TCS, reacted for both cleaved 
caspase-3 (a) and TUNEL (b). c, The TUNEL positive signals were 
located in the middle of the caspase-3 positive cells, d, e and f, The 
enlargement of the regions marked in a, b and c. (a to c: Confocal at 400 
magnification, scale bar: 50|im; d to f: scale bar: 25|J-m) 
- 1 1 2 -
•• ^BSIIESSIH BSS^^HIHHIIIHHI 
61 Su 
Fig. 20 Retina four days after injection of 0.92 nmol TCS, reacted for both 
cleaved caspase-3 (a) and TUNEL (b). c, Merged images from a and b. d 
merged image overlapped with a phase contrast image, e and f, 
Enlargement of areas marked in c and d. The double positive cells were 
indicated by arrows (a to d: Confocal at 400 magnification, scale bar: 
50|J.m; e & f: scale bar: 25|Ltm). 




Fig. 21 Retina two days after injection of 0.01 nmol RTA, reacted for both 
cleaved caspase-3 (a) and TUNEL (b). c, Merged images from a and b. d, 
Merged image overlapped with a phase contrast image. The double 
positive cells were indicated by arrows (Confocal at 400 magnification; 
scale bar: 50|im). 







Fig. 22 EM sections of saline injected control retinas at 4 day post-injection. The 
upper figure showed normal ONL cells at the top and regularly 
distributed photoreceptors at the bottom. The lower figure showed ONL 
cells at higher magnifications. (The upper: 2,000 magnification, scale bar: 
5|im; the lower: 5,000 magnification, scale bar: 2|im) 
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Fig. 23 EM sections of 0.92 nmol TCS injected retinas at 4 day. The upper figure 
showed many condensed ONL nuclei and apoptotic bodies located among 
normal cells. The lower figure was at higher magnifications. The 
enlarged and swollen mitochondria were present in the cells with 
condensed DNA and apoptotic bodies. (The upper: 2,000 magnification, 
arrow heads: condensed nuclei, scale bar: 5|jjn; the lower: 5,000 
magnification, arrow heads: apoptotic bodies, stars: swollen mitochondria, 
scale bar: 2|LLm) 
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Fig. 24 EM sections of 0.01 nmol RTA injected retinas at 2 day. The upper figure 
showed many enlarged and swollen ONL cells with swollen organelles in 
clumpy. The lower figure was at higher magnifications. Many cells lysed 
with broken cell membranes and the intracellular components extruded. 
(The upper: 2,000 magnification, stars: swollen cells, scale bar: 5|im; the 
lower: 5,000 magnification, stars: grouped lysed cells, scale bar: 2|im) 
I 
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Fig. 25 Retina one day after injection of 3 nmol of FITC. a, PI contrastaining. b, 
Location of FITC signals, showing scattered distribution over the retina, 
absence of signals in nuclei except those of INL, and concentration in the 
inner segment of INL. c. The merged images of a and b (Confocal at 400 
magnification; scale bar: 50 |im )• 
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Fig. 26 Retinas one day (a, b and c) and two days (d, e, and f) after injection of 
0.52 nmol of FITC-TCS. a and d, PI contrastaining. b, One day after the 
conjugate injection, showing signals spread over the retina, stopping 
sharply at the position of the outer limiting membrane (OLM) and 
forming a line on it (indicated by arrows), e, Two days post-injection, 
showing signals crossing the OLM, and stronger signals around the OLM 
than that in 1 day. The pigment epithelial cells were also positive, c, The 
merged image of a and b. f, the merged image of d and e (Confocal at 400 
magnification; scale bar: 50 |im ). 
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Fig. 27 Retinas at three day (a, b and c) and four day (d, e, and f) after injection 
of 0.52 nmol of FITC-TCS. a and d, PI contrastaining. b. Three days 
post-injection, showing presence of FITC labeling in photoreceptors d. 
Four days post-injection, the green signals were significantly decreased, c 
and f, Merged images. (Confocal at 400 magnification; scale bar: 50 jim ). 
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Fig. 28 Retinas one day after injection of 3 nmol of FITC, stained with anti-
glutamine synthetase activity (GS) for Miiller cells, a, GS activity, b, 
FITC labeling, c, Merged images of a and b. d, e and f, Enlargement of 
the marked areas in a, b and c. Nuclei with the strong FITC signals 
(indicated by triangles) did not correspond to the GS-positive cells 
(indicated by stars) (a, b & c: Confocal at 400 magnification, scale bar: 
50|j.m; d, e & f: scale bar: 25|am). 
% 
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Fig. 29 Retinas at one day (a, b and c) and two day (d, e, and f) after injection of 
0.52 nmol of FITC-TCS, stained with anti-glutamine synthetase (GS) for 
Muller cells, a and d, GS activity, b and e, FITC-TCS labeling, c and f, 
Merged images. In 1 day post-injection, the sharp line formed by FITC-
TCS (b) exactly overlapped with OLM. (c). (Confocal at 400 
magnification; scale bar: 50 |J.m). 
* 




Fig. 30 Retinas at three day (a, b and c) and four day (d, e, and f) after injection 
of 0.52 nmol of FITC-TCS, stained with anti-glutamine synthetase (GS) 
for Muller cells, a and d, GS activity, showing a decrease with time when 
compared with Fig. 29. b and e, FITC-TCS labeling, c and f. Merged 
images. (Confocal at 400 magnification; scale bar: 50 
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Fig. 31 Retinas three days after injection of 0.92 nmol of TCS. Sections were 
stained with both anti-glutamine synthetase (GS) (a) and TUNEL (b). c, 
Merged image, d, e and f, Enlarged images showed GS positive cells that 
were also TUNEL positive (a to c: Confocal at 400 magnification, scale 
bar: 50|im; d to f: scale bar: 25网). 




Fig. 32 Retinas one day after injection of 0.04 nmol of FITC (a, b and c) and 0.01 
nmol of FITC-RTA (d, e and f). a and d, PI contrastain. b, Showing 
absence of signals in after FITC injection, e, Only a few sites with signals 
were observed after FITC-RTA injection, c and f. Merged images. 
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Fig. 33 Retinas two days (a, b and c) and three days (d, e and f) after injection of 
0.01 nmol of FITC-RTA. a and d, PI contrastain. b and e. Showing 
unevenly scattered signals of FITC-RTA. Some signals were distribute 
along a blood vessel at 3 day (e). c and f, Merged images (Confocal at 
400 magnification; scale bar: 50 |J.m). 





Fig. 34 Retinas after injection of 0.92 nmol TCS, reacted with anit-glutamine 
synthetase (GS). a. Saline control, b, c, d and e 1，4，7 and 28 days post-
injection respectively, showing decrease of GS activity with time 
(Metamorph at 400 magnification; scale bar: 50 jim). 




Fig. 35 Retinas after injection of 0.92 nmol TCS, reacted with anti-GFAP. a, 
Saline control, b, c, d and e, 1，4，7 and 28 days post-injection 
respectively, showing an increase in GFAP expression at 1 and 4 day. 
(Metamorph at 400 magnification; scale bar: 50 |J.m). 
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Fig. 36 Retinas 4 day after injection of 0.92 nmol TCS, labeled with FITC-BS-1-
B4 for microglia, a, b and c, Saline control, d, e and f, TCS-treated. a and 
d, PI contrastaining. c and f, Merged images. (Confocal at 400 
magnification; scale bar: 50 jiim). 
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Fig. 37 Retinas after injection of 0.01 nmol of RTA, reacted with anit-glutamine 
synthetase (GS). a, Saline control, b, c and d, 1, 3 and 7 days post-
injection respectively, showing a decrease in GS activity with time. 
(Metamorph at 400 magnification; scale bar: 50 |J.m). 
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Fig. 38 Retinas after injection of 0.01 nmol of RTA, reacted for GFAP 
expression, a, b, c and d, 1, 2, 3 and 7 days post-injection respectively, a, 
One day after RTA injection, the GFAP staining was observed to increase 
in the nerve fiber layer and along the blood vessel, b, c and d, With the 
time being, GFAP staining was observed in Miiller cells (Metamorph at 
400 magnification; scale bar: 50 |im). 
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Fig. 39 Retina after injection of 0.01 nmol RTA, labeled with FITC-BS-I-B4 for 
microglia, a, PI contrastaining. b. Three days after RTA injected retina 
stained by FITC-lectin. The positive cells greatly increased than control 
or TCS sections, c, Merged image (Confocal at 400 magnification; scale 
bar: 50 |im). 




Fig. 40 Anti-GS stained RCA retinal sections, a, Saline control, b, c and d were 
0.01 nmol RCA injected retinas at 1，3 and 7 day post injection time 
respectively. The GS staining decreased with the time being (Metamorph 
at 400 magnification; scale bar: 50 jim). 
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Fig. 41 GFAP activity after injection of 0.01 nmol RCA at different time points, a 
and b, One and two days after RCA injection, the activity was observed 
to increase in the nerve fiber layer and around the blood vessel, c and d, 
With the time being, GFAP staining was observed in Miiller cells as well 
(Metamorph at 400 magnification; scale bar: 50 |im). 
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Fig. 42 FITC-BS-I-B4 labeling of O.Olnmol RCA-treated retinal section, a, PI 
contrastaining. b, Labeling three days after RCA injection. The positive 
cells greatly increased, resembling the change in the RTA section, c, 




Table 1 The effects of different doses of TCS on the three retinal cell layers (GCL, 
INL and ONL) one month after injection. The effects were evaluated at 
peripheral (a) and central (b) retinas respectively. 
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Table 1. Effect of TCS on retinal cell number one month after injection 
-dose-response studies. 
a. Peripheral retina 
Dose No. Mean of Standard Difference 
group of cell numbers error between groups 
(nmol) rats GCL INL O N L G C L INL O N L G C L INL ONL 
Saline 6 19.24 200.76 706.14 0 . 5 9 ^ 3 4 . 0 9 
p>0.05 p>0.05 pcO.Ol* 
0.46 6 18.17 196.96 578.21 0.29 8.19 9.81 
p>0.05 p>0.05 p>0.05 
0.92 6 17.29 181.07 518.91 0.63 10.50 22.83 
1.84 5 16.89 157.81 288.11 0 . 7 1 1 5 . 2 6 19.81 P>0.05 p>0.05 pcO.Ol* 
b. Central retina 
Dose No. Mean of Standard Difference 
group of cell Number error between groups 
(nmol) rats GCL I N L O N L G C L INL O N L G C L INL ONL 
Saline 6 32.08 311.06 941.78 1.76 22.07 66.93 
p>0.05 p>0.05 p<0.01* 
0.46 6 26.78 271.26 639.19 0.64 7.84 40.77 ^ ^ 
^ ^ 27.70 242.76 690.01 0.76 13.21 39.32 P>0.05 p>0.05 
p>0.05 p>0.05 p<0.01* 
1.84 5 25.28 190.70 255.58 1.89 5.96 60.08 ^ ^ ^ 
Graph 1 Cell numbers in three retinal cell layers of four TCS dose groups (n=23) 
in peripheral (a) and central retinas (b). In both peripheral (a) and central 
(b) retinas, the effect of TCS on ONL cell reduction was very significant, 
both p<0.01. At both sites, the effect of TCS on INL cells was also 
significant, both p<0.01. The effect of TCS on GCL at both sites was not 
significant, both p>0.05. 
* 
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Graph 1. Comparison of effect of TCS on different retinal layers 
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Graph 2 Cell numbers in three retinal cell layers of four TCS dose groups (n=23) 
in peripheral (a) and central retinas (b). At both INL (a) and ONL (b) 
layers, the effect of TCS, as well as the difference between the peripheral 
and central retina were very significant p <0.01. 
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Graph 2. Comparison of effect of TCS on different retinal regions 
350 -1 
300 - r ^ 
！ ： 广 广 , r § E s ^ 
“ � - - J I 厂 “ — 
T I M . I r l , 1 1 I I , 




1000 - T 
fe 800 - _ 
I 600 - P ^ i I ° Peripheral 
1 4 � � - I _ � _ ^ 
Saline 0 .46 0 .92 1.84 
Dose (nmol) 
b. ONL 
Graph 3 Comparison of ONL and INL cell numbers at peripheral (a) and central 
(b) retains of different TCS dose groups (n=23). At both retinal sites, the 
differences between INL and ONL cell death caused by TCS were very 
significant, p<0.01. 
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Graph 3. Comparison of effect of TCS on different layers in a 
specific retinal region 
8 0 0 -1 
700 - ^ • • 
• • • —— 
• • • 口丨 NL 
1 300 • • • . i l O N k 
T i L i x L l 
Saline 0.46 0.92 1.84 
Dose (nmol) 
a. Peripheral retina 
1200 
1000 - J 
I 800 • 
i 600 • ^ _ l a i N L 
• • • " O N L 
o 400 • • • 
Saline 0.46 0.92 1.84 
Dose (nmol) 
b. Central retina 
Table 2 a. Comparison of the experimental (TCS) and control (saline) retinal thickness 
at each time point, b, Changes in percentage retinal thickness at different time 
points after injection of 0.92 nmol of TCS injection. 
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Table 2. Effect of TCS (0.92 nmol) on retinal thickness 
a. Thickness compared with control 
Survival Peripheral retina thickness (|im) Central retina thickness (|im) 
time Experimental C o n t r o l p E x p e r i m e n t a l C o n t r o l p ~ 
(day) 
1 192.02土4.17 178.46土 6 . 4 6 0 0 8 2 5 3 . 5 2 土 9 . 2 4 2 3 5 . 6 2土10. 4 2 0.23 
3 174 .31 土4.79 167.59土2.24 0 . 1 2 2 2 8 . 2 2 土 5 . 1 0 2 2 7 . 6 3 + 5 . 6 8 0 ? ^ 
7 1 2 0 . 8 0土 4 . 9 6 1 6 8 . 9 6土 2 . 7 2 < 0 . 0 1 * 1 6 1 . 8 4土 7 . 9 6 2 2 1 . 8 1 ± 4 . 9 1 < 0 . 0 1 * 
^ 131 .91 土8.38 167.32土1.62 0 . 0 1 * 1 9 3 . 6 5 + 2 . 2 2 2 2 3 . 2 1 土 4 . 9 0 O o F " 
b. Changes in thickness (% control) 
Survival Mean (%) 土 s.e. Difference " " “ D i f f e r e n c e “ 
time between groups between 
Peripheral Central Peripheral Central peripheral and 
(day) 
central retina 
1 ns ns 
3 ；^  ^ ^ ^ ns ns  
7 - 2 2 . 0 0 土 4 . 2 7 -21.12土 3 .27 ^〈。川* P < 0 川 * ——“—— 
^ - 2 1 . 1 7 土4.99 -13.02土 2 . 6 8 ns  
ns: not significant 
Graph 4 Changes in percentage retinal thickness. Changes at peripheral (a) and 
central (b) regions showed similar trends (each group, n=5). In both 
peripheral and central retina, there is no statistically significant difference 
in percentage retinal thickness between 1 day and 3 day, or between 1 
week and 1 month, but there is statistical significance between 3 day and 
1 week (p<0.01). There is no statistically significant difference between 
the peripheral and central retinas. 
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Graph 4. Retinal thickness at different times after TCS injection 
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Table 3 a. Comparison between the experimental (RTA) and control (saline) retinal 
thickness at each time point, b, Changes in percentage retinal thickness at 
different time points after injection of 0.01 nmol of RTA. 
* 
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Table 3. Effect of TCS (0.92 nmol) on retinal thickness 
a. Thickness compared with control 
Survival Peripheral retina thickness (|am) Central retina thickness (|Lim) 
time Experimental C o n t r o l p Experimental Control p 
(day) 
i 2 0 5 . 0 + 1 1 . 2 1 8 4 . 3 土 7 . 8 < 0 . 0 1 * 2 8 7 . 0 土 12.8 238.0土 1 0 . 7 < 0 . 0 1 * 
3 2 1 5 . 3 土 8.3 1 7 4 . 2 土 7 . 9 < 0 . 0 1 * 2 7 7 . 8 土 6 . 9 2 3 0 . 2土 6 . 0 ~ ~ < 0 . 0 1 * 
7 152.0 土 5.1 1 7 8 . 2 + 6 . 2 < 0 . 0 1 * 1 8 8 . 6 土 5 . 1 220.2土 5 . 5 < 0 . 0 1 * 
b. Changes in thickness (% control) 
Survival Mean (%) 土 s.e. Between Difference 
time time groups between 
(day) Peripheral Central Peripheral C e n t r a l ~ peripheral and 
central retina 
i 11.0 土2.0 20.7+1.9 p<0.01*  
I T O T 2 0 . 7 土 0.7 P>0.05 ~ ^ ~ 
——^ TT^ p<0.01* p<0.01*  
7 -14.6 土 2.3 -13.3+0.5 ^ ^ p>0.05 
Graph 5 Changes in percentage of retinal thickness at different time points after 
injection of 0.01 nmol of RTA (each group, n = 5). One day after RTA 
injection, the experimental retinal became significantly swollen at both 
retinal sites (peripheral and central). One week after the treatment the 
retinal thickness significantly decreased. Significant difference between 
the peripheral and central retinas was seen only at one day. 
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Graph 5. Retinal thickness at different times after TCS injection 
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Table 4 a. Comparison between the experimental (RCA) and control (saline) retinal 
thickness at each time point, b, Changes in percentage retinal thickness at 
different time points after injection of 0.01 of nmol of RCA. 
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Table 4. Effect of TCS (0.92 nmol) on retinal thickness 
a. Thickness compared with control 
Survival Peripheral retina thickness (|im) Central retina thickness (|Lim) 
time Experimental Control p Experimental Control p 
(day) 
i 187.3 土4.9 169.0+2.2” ~<0.01*~271.2+11.8 237.2+5.5 <0.01* 
3 203.8+9.9 176.6土 5 . 8 < 0 . 0 5 * 2 9 0 . 3土 10.8 223.9 土 9 . 2 < 0 . 0 1 * 
7 158.4 土4.1 1 7 0 . 2 + 6 . 2 = 0 . 0 1 * 2 1 8 . 0 + 8 . 6 2307+7.5 <0.01* 
b. Changes in thickness (% control) 
Survival Mean(%) 土 s.e. Difference Difference 
time between groups between 
Peripheral Central Peripheral C e n t r a l p e r i p h e r a l and 
(day) 
central retina 
i 7.6 土 1.3 17.6 土 2.4 ^>005 
3 12.7 土 3.3 21.3 土4.2 口>0.05 p>0.05 ^ ^ 
——^ … p<0.01* pcO.Ol*  
7 -10.9 土 2.2 -11.8土 1.4 P P p>0.05 
Graph 6 Changes in percentage retinal thickness at different time points after 
injection of 0.01 of nmol of RCA (each group, n 二 5). One day after RCA 
injection, the experimental retinal became significantly swollen at both 
retinal sites (peripheral and central). One week after the injection the 
retinal thickness significantly decreased. No significant difference 
between the peripheral and central retinas was seen at any time point. 
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Table 5 Comparison of changes in retinal thickness caused by different RIPs, at 
different time points after injection of the RIPs. Dosages used were 0.92 nmol 
of TCS, 0.01 nmol of RTA, or 0.01 nmol of RCA. 
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Table 5 Compare the effects of different RIPs on retinal thickness 
Retinal site RIPs compared 1 day 3 days 7 days 
TCS vs RTA >0.05 <0.05* >0.05 
^ T C S vs RCA >0.05 >0.05 >0.05 
Peripheral 
RTA vs RCA >0.05 >0.05 >0.05 
TCS vs RTA <0.01* <0.01* >0.05 
TCS vs RCA >0.05 <0.05* >0.05 
Central 
RTA vs RCA >0.05 >0.05 >0.05 
Graph 7 Comparison of changes in retinal thickness caused by different RIPs, at 
different time points after injection of the RIPs. Dosages used were 0.92 nmol 
of TCS, 0.01 nmol of RTA, or 0.01 nmol of RCA. At one day post-injection, 
the increase in thickness was significantly higher in the RTA group than in the 
other two groups in central retinas. At three day post-injection, the increase 
was significantly higher in the RTA group than in the TCS group at both retinal 
sites, and higher in the RCA group than in the TCS group at the central. 
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Graph 7. Retinal thickness at different times after RIP injection 
(Combined data from Graphs 4, 5 & 6) 
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Table 6 Histophathological scores on retinitis at different times after injection of 0.92 
nmol of TCS, 0.01 nmol of RTA, or 0.01 nmol RCA. 
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Table 6. Pathological changes in retina after injection of RIPs 
(Scores allocated according to system of Cousins et al (1989) and Brandt et al (1997) 
Survival time Peripheral retina Central retina 
Vitreous Retinal Retinal Vitreous Retinal Retinal 
(days) 
infiltrate cytology inflammation infiltrate cytology inflammation 
i 0.8+0.3 0+0 0.4 土 0.1 0+0 
^ , ^ 3 0.1+0.1 0+0 0+0 0.3+0.1 0+0 0+0 
Control - - - -
7 0.3 土 0.1 0.1 土0.1 0.6 土 0.2 0+0 
i 1.2土0.1 0+0 0.6 土0.2 1+0.2 0 . 4土0 . 2 ^ 
^ 3 0.7+0.2 0+0 0.3+0.1 0.5+0.2 0+0 0 . 3土0 . 2 ^ 
1 V^ o 
7 0.7 土 0 . 2 0 . 1 土 0.1 0.3 土 0.1 0.9 土 0 . 2 0 . 2 + 0 . 2 0.6 土0.1 ~ ~ 
i 1 . 3土0 . 4 0 . 6 土 0.1 0.6+0.3 1 . 5 + 0 . 2 0 . 8 土0.1 0.9 土 0.4 
RTA ^ 1 .2+0.11 .5土0.2 2.4土0.2 1.2土0.21.9土0.1 2.9土0.1 ^  
7 1 . 9土 0 . 3 1 3 土0.5 2.4 土 0.4 2 . 1 + 0 . 3 1 . 4 + 0 . 5 2.7 土 0.3 
1 1.3 土0.3 0+0 0.7土 0.2 1 . 5 + 0 . 2 0 . 3 土0.1 1.1 土0.2 
_ • 3 1 . 5 + 0 . 3 1 . 2 + 0 . 1 2.4+0.1 1 . 3 + 0 . 2 1 . 9 + 0 . 1 2.9+0.1 ^  
RCA — - — - -
7 1 . 5土0 . 2 1 . 3 土 0.2 2.4+0.2 1.8 土0 . 3 1 . 6土0 . 2 2.9 土0.3 
Table 7 Histophathological scores on vitreous infiltrate at different times after injection 
of 0.92 nmol of TCS, 0.01 nmol of RTA, or 0.01 nmol RCA. a, Comparison 
between control and different RIP groups, b, Comparison between different 
RIP groups at both peripheral and central retinas, c, Compare between the 
peripheral and central retinas. 
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Table 7 Vitreous infiltrate 
a. Comparison with control group and between different RIP groups 
RIPs Peripheral retina Central retina 
compared 3 d a y s 7 d a y s 3 d a y s 7 d a y s 
C vs TCS p>0.05 p>0.05 p>0.05 p>0.05 p>0.05 p>0.05 
^ C vs RTA p>0.05 p < 0 . 0 5 * p < 0 . 0 1 * p < 0 . 0 5 * p < 0 . 0 5 * p < 0 . 0 1 * 
^ ^ C vs RCA p>0.05 p<0.01*p<0.05*“““p<0.05* p < 0 . 0 5 * p < 0 . 0 5 * 
TCS vs RTA p>0.05 p > 0 . 0 5 p < 0 . 0 1 * p>0.05 p>0.05 p>0.05 
TCS vs RCA p>0.05 p > 0 . 0 5 p > 0 . 0 5 p>0.05 p>0.05 p>0.05 
RTA vs RCA p>0.05 p>0.05 p>0.05 p>0.05 p>0.05 p>0.05 
b. Comparison between different time groups 
Site Time groups “ C o n t r o l " " “ TCS. RTA RCA 
Peripheral Iday vs 3days p>0.05 p>0.05 p>0.05 p>0.05 
retina 3days vs 7days p>0.05 p>0.05 p>0.05 p>0.05 
Central Iday vs 3days p>0.05 p>0.05 p>0.05 p>0.05 
retina 3days vs 7days ^ p > 0 . 0 5 p>0.05 p>0.05 p>0.05 
c. Comparison between peripheral and central regions 
Control f ^ RTA R ^ 
r ^ >0.05 >0.05 >0.05 >0.05 
3 days >0.05 >0.05 >0.05 >0.05 
7 days >0.05 >0.05 >0.05 >0.05 
Table 8 Histophathological scores on retinal cytology at different times after injection 
of 0.92 nmol of TCS, 0.01 nmol of RTA, or 0.01 nmol RCA. a. Comparison 
between control and different RIP groups, b, Comparison between different 
RIP groups at both peripheral and central retinas, c, Compare between the 
peripheral and central retinas. 
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Table 8 Retinal cytololgy 
a. Comparison with control group and between different RIP groups 
Compare Peripheral retina Central retina 
between groups Iday 3 d a y s 7 d a y s Iday 3 d a y s 7 d a y s “ 
C vs TCS p>0.05 p > 0 . 0 5 p > 0 . 0 5 p>0.05 p>0.05 p>0.05 
C vs RTA p < 0 . 0 1 * p < 0 . 0 5 * p < 0 . 0 5 * p < 0 . 0 1 * p c O . O l * p < 0 . 0 5 * 
C vs RCA p>0.05 p<0.05* p<0.05* p>0.05 p<0.01* p<0.01* 
TCS vs RTA p c O . O l * p < 0 . 0 5 * p<0.05* pcO.Ol* p c O . O l * p < 0 . 0 5 * 
TCS vs RCA p>0.05 p<0.05* p<0.05* p>0.05 p<0.01* p<0.05* 
RTA vs RCA p<0.01* p>0.05 p>0.05 p>0.05 p>0.05 p>0.05 
b. Comparison between different time groups 
Site Time groups Control TCS. RTA RCA 
Peripheral Iday vs 3days p>0.05 p>0.05 ~~p>0.05 p < 0 . 0 5 * ^ 
retina Sdays vs 7days p>0.05 p>0.05 p>0.05 p>0.05 
Central Iday vs 3days p>0.05 p>0.05 p>0.05 P<0.01* 
retina 3days vs 7days p>0.05 p>0.05 p>0.05 p>0.05 
c. Comparison between peripheral and central regions 
Control TCS Wa R ^ 
f d ^ >0.05 >0.05 >0.05 >0.05 
3 days >0.05 >0.05 >0.05 <0.05* 
7 days >0.05 >0.05 >0.05 >0.05 
Table 9 Histophathological scores on retinal inflammation at different times after 
injection of 0.92 nmol of TCS, 0.01 nmol of RTA, or 0.01 nmol RCA. a, 
Comparison between control and different RIP groups, b, Comparison between 
different RIP groups at both peripheral and central retinas, c, Compare between 
the peripheral and central retinas. 
-141 -
Table 9 Retinal inflammation 
a. Comparison with control group and between different RIP groups 
Compare Peripheral retina Central retina 
between groups I d ^ 3days 7days Iday 3 d a y s 7 d a y s “ 
C vs TCS p>0.05 p>0.05 p>0.05 p>0.05 p>0.05 p>0.05 
C vs RTA p>0.05 p<0 .01*p<0 .01* p>0.05 p < 0 . 0 1 * p < 0 . 0 1 * 
C vs RCA p>0.05 pcO.Ol*p<0.01*~~p<0.05* p<0.01* p<0.01* 
TCS vs RTA p>0.05 p<0 .01*p<0 .01* p>0.05 p < 0 . 0 1 * p < 0 . 0 1 * 
TCS vs RCA p>0.05 p<0 .01*p<0 .01* p>0.05 p < 0 . 0 1 * p < 0 . 0 1 * 
RTA vs RCA p>0.05 p>0.05 p>0.05 p>0.05 p>0.05 p>0.05 
b. Comparison between different time groups 
Site Time groups ~Con t ro l " "“ TCS. RTA RCA 
Peripheral Iday vs 3days p>0.05 p>0.05 p<0.05* p < 0 . 0 5 * ^ 
retina 3days vs 7days p>0.05 p>0.05 p>0.05 p>0.05 
Central Iday vs 3days p>0.05 p>0.05 p<0.05* p<0.05* 
retina 3days vs Vdays p>0.05 p>0.05 p>0.05 p>0.05 
c. Comparison between peripheral and central regions 
Peripheral vs central Control T ^ RTA RCA 
f d ^ >0.05 >0.05 >0.05 >005 
3 days >0.05 >0.05 >0.05 <0.05* 
7 days >0.05 >0.05 >0.05 >005 
Graph 8 Histophathological scores on vitreous infiltrate (a and b) and retinal cytology (c 
and d) at different times after injection of 0.92 nmol of TCS, 0.01 nmol of RTA, 
or 0.01 nmol RCA. The scores, especially those on retinal cytology, for both 
the RTA and RCA groups were significantly higher than those for the control 
and TCS retinas. 
* 
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Graph 8 Pathological changes 
(Mean scores on pathological parameters versus survival time) 
a. Peripheral vitreous infltrate b. Central vitreous infiltrate 
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Graph 8 (cont.) Histophathological scores on retinal inflammation (e and f) at different 
times after injection of 0.92 nmol of TCS, 0.01 nmol of RTA, or 0.01 nmol 
RCA. The scores for both the RTA and RCA groups were significantly higher 
than those for the control and TCS retinas. 
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Graph 8. (Cont.) 
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APPENDICES 
Appendix A: Source of Materials 
Toxins 
Trichosanthin, T 0794; ricin A chain, L 9514; and ricinus communis agglutinin, L 7886: 
from Sigma Co., U.S.A. 
Tracers 
Fluorescein isothiocyanate (FITC) from Pierce; IL, U.S.A. 
Conjugates of FITC-TCS and HYC-RTA self-made. 
Reagents for Immunohistochemistry 
Rabbit anti-cleaved caspase-3 (Asp 175) polyclonal antibody: from Cell Signaling 
Technololgy, Inc.; MA, U.S.A. 
Mouse anti-glial fibrillary acidic protein (GFAP) monoclonal antibody and mouse anti-
glutamine synthetase (GS) monoclonal antibody: from Chemicon International, Inc.; CA, 
U.S.A. 
FTTC-GS-I-B4： from Sigma Co., U.S.A. 
Cy™3-conjugated anti-mouse and Cy™3-conjugated anti-rabbit antibodies: from 
Jackson ImmunoResearch Laboratories, Inc.; PA, U.S.A. 
Propidium iodide (PI): from Sigma Co., U.S.A. 
Kits 
Anti-mouse and anti-rabbit ABC Kits: from Vector Laboratories; CA, U.S. A. 
Peroxidase In Situ Apoptosis Detection Kit: from Intergen Company; NY, U.S.A. 
Fluorescein In Situ Cell Death Detection Kit: from Boehringer Mannheim, U.S.A. 
Others 
Proteinase K: Sigma Co.; U.S.A. 
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Slide-A-Lyzer Dialysis Cassettes: from Pierce; IL, U.S.A. 
Centrifugal filters and tubes (lOK NMWL Membrane 4ml VOL): from Biomax, U.S.A. 
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Appendix B: Dosages for Vitreous Chamber Injection 
Chemical M. Wt Concentration Dose (4 |j.l per injection) 
(kDa) mg/ml |j.M nmol jj,g 
TCS 26.0 0.07 2.5 0.01 0.26 
2.99 115.0 0.46 11.96 
5.98 230.0 0.92 23.92 
11.96 460.0 1.84 47.84 
RTA 30.6 0.08 2.5 0.01 0.31 
0.16 5.0 0.02 0.62 
0.31 10.0 0.04 1.24 
0.54 17.5 0.07 2.17 
RCA 120.0 0.30 2.5 0.01 1.20 
0.60 5.0 0.02 2.40 
1.20 10.0 0.04 4.80 
2.40 20.0 0.08 9.60 
FITC 0.4 0.004 10.0 0.04 0.02 
0.30 755.0 3.02 1.21 
FITC-TCS 28.4 3.69 130.0 0.52 14.77 
FITC-RTA 32.2 0.08 2.5 0.01 0.32 
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Appendix C: Protocol of Conjugating Fluorescein to Proteins 
1. Dialysis of proteins: trichosanthin (TCS) or ricin A chain (RTA) 
i) Hydrate a Slide-A-Lyzer Dialysis Cassettes with an appropriate size 
buoy in conjugation buffer (0.1 M carbonate/ bicarbonate buffer, pH 
9.5) for 2 minutes 
ii) Dilute protein (TCS or RTA) at 1 mg/ml in the conjugation buffer 
iii) Inject 0.5 ml air and 1 ml diluted protein into the cassette through its 
port 1 with a 2.5 ml syringe and 18-gauge needle 
iv) Rinse the syringe with 1 ml conjugation buffer and inject it into the 
cassette through port 2; when the needle in, withdraw all of the air 
from the cassette 
V) Dialysis the cassette in a 2-liter conjugation buffer at 4°C with stirring 
overnight 
2. Label protein with fluorescein isothiocyanate (FITC) 
i) Remove protein solution from the cassette through port 3 with a new 
2.5 ml syringe and 18-gause needle following injection of 2.5 ml air 
into it . 
ii) Dissolve FITC at the concentration of 200 ^g/200 \x\ in the 
conjugation buffer and immediately add it to the protein solution at 
the ratio of 200 |J.l FITC: I ml dialyzed protein solution 
iii) Incubate the mixture at 3TC in the dark overnight. 
3. Dialysis of the FITC- protein conjugate 
i) Hydrate a new cassette in 0.01 M PBS, pH 7.2-7.4. 
ii) Inject the conjugated solution into the cassette. 
iii) Rinse the syringe with 0.5 ml conjugation buffer and inject it into the 
cassette, then withdraw all the air in it. 
iv) Dialysis the cassette in a 2-liter PBS at 4°C with stirring in the dark 
overnight. 
-141 -
4. Measure the concentration of the conjugate 
i) Remove the conjugate from the cassette to a concentration tube 
ii) Get 3 |il of the product diluted to 100 folds in double distilled water 
(d. d. W) 
iii) Run the UV-visible spectrophotometer ready to read the absorbance 
of the diluted solution 
iv) Fill a clean cuvette with d. d. W and auto-zero the reading at the 
wavelength of 495 nm 
V) Empty the cuvette and fill it with 150 |LL1 diluted conjugate solution, 
then read the absorbance at the wavelength of 495 nm (for FITC) 
vi) Rinse the cuvette with d. d. W for three changes, then fill it with d. d. 
W and auto-zero the reading at the wavelength of 280 nm 
vii) Refilled the cuvette with another 150 |J,1 diluted product, then read its 
absorbance at the wavelength of 280 nm (for protein) 
viii) Calculate the F/P molar ratio of FITC /Protein conjugate according to 
the following equation: 
u 1 c m 2 . 7 7 x A 4 9 5 
Molar F/P = �  
A 2 8 0 - ( 0 . 3 2 x A 4 9 5 ) 
ix) Work out the concentration of the labefed protein in another formula 
n � … . � �1  A495 X di lut ion factor Protein concentration (M)= 
72,000 X Molar F/P 
as below (72,000 in the equation is the approximate molar extinction 
coefficient of FITC at 495 nm, and the dilution factor is 100): 
5. Concentrate the product (if necessary) 
i) Transfer the conjugate product to a centrifugal filter and tube 
ii) Concentrate in a centrifuge within a No.809 rotor at 4°C, 3900RPM, 
for 15 minutes with well balancing, which can be repeated when in 
need 
iii) Transfer the solution in the filter to a small centrifuge tube in dark 
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iv) Measure the absorbance and calculate the concentration of the final 
product as above 
6. Store the final conjugated product at 4°C in dark 
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Appendix D: Electronic Microscope Methods 
1. Rats were perfused through the heart with 0.86% saline followed by 4% 
paraformaldehyde 
2. Eyes were removed (with labeled temporal parts) and immediately immersed in 
2.8% glutaraldehyde and 1.8% paraformaldehyde in O.IM pH 7.4 phosphate 
buffer (PB) on ice with shaking 6 hours 
3. The corneas and lenses were removed and rinsed three times in mammalian 
hepes buffer containing 140 mM NaCl, 30 mM Hepes, and 5 mM CaCl2,pH7.2. 
4. The eyecups were then transferred to 0.2 M sodium cacodylate in 4% sucrose on 
ice overnight 
5. The eye cups were subsequently cut into small pieces at 1 mm wide an 5 mm 
long with the optic nerve preserved at on end 
6. The tissues were post-fixed in 1% osmium tetroxide for 2 houra at room 
temperature 
7. After rinsing in distilled water for 2-5 min once? and then in cacodylate-sucrose 
twice, 5 min each, the tissues were dehydrated as follows: 
20% 15 min 
35% ethanol 15 min 
50% 15 min 
70 15 min 
80 15 min 
90 15 min 
95 15 min each 
100% X 3 15 min each 
propylene oxide x 2 5-10 min each 
8. The tissues were then infiltrated with Epon 812 as follows: 
1: 1 (propylene oxide: Epon) 4 hour 
1:2 4 hour 
1:3 4 hour 
pure Epon 812 overnight 
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9. The tissues were embedded and polymerizated at 70°C for 48 hours 
10. Thin sections were cut at 70-80 nm 
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Appendix E: Histological Methods 
Process of paraffin sections of retina 
1. Rats were perfused through the heart with 0.86% saline followed by 4% 
paraformaldehyde (PFA) 
2. Eyes were removed (with labeled temporal parts) and immediately immersed in 
4% PFA at 4 � C overnight 
3. The next day the corneas were cut by a scalpel and the inferior corneas as well as 
the lens were removed; then the Va eye cups were processed 
4. The timing of retina process was as below: 
70%, 80% and 95% alcohol 1 hour each 
3x absolute alcohol 20 minutes each 
2x xylene 20 minutes each 
4x wax 20 minutes each 
5. The eyes were embedded in paraffin and finally cut at 4|im. 
Process of cryostatic sections of retina 
1. The procedures were the same as above until the inferior corneas and lenses were 
removed 
2. The eye cups were immersed in 10% and 20% sucrose at 4°C for 2 hours each 
� 
3. The tissues were transferred to 30% sucrose at 4°C overnight 
4. The eye were then submerged in OCT for half hour and finally embedded in 
OCT 
5. The blocks were stored at -70°C 
6. The sections were cut with a cryostat at 20}im and stored at -20 °C 
- 1 6 2 -
Appendix F: Protocols of TUNEL 
Protocol of TUNEL for DAB development (paraffin sections) 
1. Deparaffm in xylene three changes for 5 minutes each 
2. Rehydrate in absolute, 95%, 80% and 70% alcohol for 5 minutes each 
3. Wash in 0.0IM pH7.4 PBS three changes for 5 minutes each. 
4. React with freshly diluted 20 )j.g/ml proteinase K in 0.01 M PBS directly on the 
slides for 15 minutes 
5. Wash in O.OIM PBS three changes for 5 minutes each. 
6. Equilibrate with equilibration buffer for 5 minutes 
7. Incubate with TdT enzyme at the half concentration of working strength 
recommended by the manufacture in a humid chamber at 37°C for one hour 
8. Wash in the working strength stop/ wash buffer for 10 minutes 
9. Rinse in 0.01 M PBS three changes for 2 minutes each. 
10. Incubate with anti-digoxigenin peroxidase conjugate in a humid chamber at room 
temperature for half hour 
11. Wash in 0.01 M PBS three changes for 5 minutes each 
12. Develop color in the freshly made DAB mixture, every 50 ml of which contains 
46 ml 0.05 M pH 7.6 Tris-HCl, 3 ml nickel ammonium sulfate and 1 ml 
10 mg/ml DAB. 0.3% H2O2 is added to the mixture just before use according to 
the ratio 1 [il: 1 ml of the mixture. Normally, the time for color reaction ranges 
from 3 to 5 minutes, not longer than half hour. 
13. Wash in tap water for 5 minutes 
14. Dehydrate and cleared in 70%, 80%, 95%, absolute alcohol three times and 
xylene three times for 2 minutes each. 
15. Mount the slides 
P.S. All procedures are performed at room temperature except specified. 
Protocol of TUNEL for fluorescence observation (paraffin sections) 
1. The same steps as above until after reaction with proteinase K 
2. Wash in 0.01 M PBS three changes for 5 minutes each. 
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3. Incubate with TUNEL reaction mixture according to the manufacture's 
recommendation in a dark humid chamber at 37°C for one hour 
4. Wash in 0.01 M PBS three changes for 5 minutes each 
5. Mount with glycerol 
Protocol of TUNEL for fluorescence observation (cryo sections) 
1. Wash in 0.01 M PBS three changes for 5 minutes each 
2. React with freshly diluted 20 M-g/ml proteinase K in 0.01 M PBS directly on the 
slides for 15 minutes 
3. The subsequent steps are the same as above 
Protocol of double staining with propidium iodide (PI) 
1. TUNEL is carried out according to the same steps as in the above fluorescence 
protocol until before mounting 
2. React with 10 M-g/ml PI for 1 minute 
3. Rinse in 0.01 M PBS three changes for 5 minutes each 
4. Mount with glycerol 
Protocols for double staining with 4',6 diamidino-2-phenvlindole (DAPI) 
1. TUNEL is carried out according to the same steps as in the above fluorescence 
protocol until before mounting 
2. React with 1 p-g/ml DAPI for 10 minutes 
3. Rinse in 0.01 M PBS three changes for 5 minutes each 
4. Mount with glycerol 
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Appendix G: Protocols of Immunohistochemistry Staining 
Protocol for paraffin sections with ABC Kit and DAB color development 
1. Deparaffm in xylene three changes for 5 minutes each 
2. Rehydrate in absolute, 95%, 80% and 70% alcohol for 5 minutes each 
3. Wash in 0.01 M pH7.4 PBS three changes for 5 minutes each. 
4. Block endogenous reactivity with 10% normal horse serum (NHS) in 0.01 M 
PBS for half hour 
5. Incubate with primary antibody diluted in 0.01 M PBS containing 0.5% NHS 
and 0.5% Triton X-100 in a humid chamber overnight (>16 hours) 
6. Rinse in 0.0 IM PBS three changes for 10 minutes each 
7. Incubate with proper secondary antibody diluted to 1:200 in the same medium 
as the primary in a humid chamber for 2 hours. 
8. Wash in 0.01 M PBS for another three changes for 10 minutes each 
9. Incubate in ABC complex diluted to 1: 300 in O.OIM PBS containing 0.3% 
Triton X-100 in a humid chamber for 1 hour 
10. Rinse in O.OIM PBS twice for 10 minutes each 
11. Wash in 0.05M pH 7.6 Tris-HCl once for 10 minutes 
12. Develop color in the freshly made DAB mixture, every 50 ml of which contains 
» 
46 ml 0.05 M pH 7.6 Tris-HCl, 3 ml nickel ammonium sulfate and 1 ml 
10 mg/ml DAB. 0.3% H2O2 is added to the mixture just before use according 
the ratio I |J.l: 1 ml of the mixture. Normally, the time for color reaction ranges 
from 3 to 5 minutes, not longer than half hour. 
13. Wash in tap water for 5 minutes 
14. Dehydrate and cleared in 70%, 80%, 95%, three changes of absolute alcohol 
and three changes of xylene for 2 minutes each. 
15. Mount the slides 
P.S. All procedures are performed at room temperature. 
Protocol for cryo sections with ABC Kit and DAB color development 
1. Wash in 0.01 M PBS three changes for 5 minutes each 
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2. Block endogenous activity with 10% normal horse serum (NHS) in 0.01 M PBS 
for half hour 
3. The following steps are the same as the above protocol. 
Protocol for sections and fluorescein-coniugated antibody 
1. The same steps as above were carried out until incubation with secondary 
antibody 
2. Incubate with fluorescein-conjugated secondary antibody diluted in the above 
same medium in a dark humid chamber for two hours 
3. Rinse in 0.01 M PBS three changes for 10 minutes each 
4. Mount with glycerol 
Double staining with TUNEL 
1. IHC staining is performed according to the same steps as in the above 
fluorescence protocol until before mounting 
2. Incubate with TUNEL reaction mixture according to the manufacture's 
recommendation in a dark humid chamber at 37°C for one hour 
3. Wash in 0.01 M PBS three changes for 5 minutes each 
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